Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Bordeaux
Clinical trial register · France

Clinical Trials in Bordeaux, 2026

Every study on the ClinicalTrials.gov registry that lists a site in France and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 9729 matching records held by the registry are in this view. Synced 14 Nov 2026, 03:18 UTC
9729
Studies in scope
all four open statuses
6052
Recruiting now
open to new participants
1030
Lead sponsors
across recruiting studies
Top sites
Paris 2848 Lyon 1397 Bordeaux 1393 Marseille 1290 Lille 1276

Trials with a site in Bordeaux

1393 of 9729 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in France
Start
Recruiting
Assistance Publique Hopitaux De Marseille
Phase 1/2
40
Angers, Bordeaux, Lyon, Marseille, Nancy, Paris, Strasbourg
2032-02
Not yet open
Boehringer Ingelheim
Phase 3
68
Bordeaux, Bron, Paris, Strasbourg, Villejuif
2027-03-04
Not yet open
Risk-reducing Strategies, Including Fimbriectomy, in Women With a Germline Mutation Predisposing to Ovarian or Pelvic Cancer
NCT06726330Tubo-ovarian Carcinoma, High-grade Serous Carcinoma, Primary Peritoneal Carcinoma Stage III, Primary Peritoneal Carcinoma Stage IV
Centre Oscar Lambret
Not applicable
1,100
Lyon, Toulouse, Valenciennes, Bordeaux, Caen, Clermont-Ferrand, Dijon, Grenoble
2027-03
Not yet open
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Phase 3
92
Strasbourg, Toulouse, Bordeaux, Bron, Paris, Rennes
2027-02-03
Not yet open
A Trial Evaluating the Anti-tumor Activity of Antibody-based Therapies in Metastatic Cancer Patients
NCT07936422NSCLC (Advanced Non-small Cell Lung Cancer), Urothelial Cancer, Pan-rare Tumor With no T-DXd Approvals, Pan-frequent Tumors With no T-DXd Approvals
Centre Leon Berard
Phase 2
200
Bordeaux, Lyon, Nice, Paris, Toulouse, Villejuif
2027-02
Not yet open
University Hospital, Bordeaux
Observational
500
Bordeaux
2027-02
Not yet open
Boston Scientific Corporation
Not applicable
200
Bordeaux
2027-01-20
Not yet open
Nantes University Hospital
Observational
553
Angers, Bordeaux, Brest, Caen, Chambray-lès-Tours, Le Mans, Nantes, Rennes
2027-01-01
Not yet open
What is the Role of the Exposome in Pulmonary Hypertension
NCT07172334Pulmonary Arterial Hypertension (PAH), Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
Poitiers University Hospital
Observational
150
Bordeaux, Brest, Le Kremlin-Bicêtre, Lille, Lyon, Nancy, Poitiers, Saint-Etienne
2027-01
Not yet open
Centre Hospitalier Universitaire de Nīmes
Phase 2
108
Nîmes, Besançon, Bordeaux, Nantes, Paris, Strasbourg, Toulouse
2027-01
Not yet open
Elsan
Phase 3
636
Bordeaux, Nîmes, Perpignan
2027-01
Not yet open
University Hospital, Lille
Observational
400
Béziers, Bordeaux, Brest, Caen, Lille, Lyon, Marseille, Nice
2027-01
Not yet open
Assistance Publique Hopitaux De Marseille
Phase 4
224
Amiens, Avignon, Besançon, Bordeaux, Clermont-Ferrand, Lille, Lyon, Marseille
2027-01
Not yet open
Boehringer Ingelheim
Phase 3
270
Angers, Bordeaux, Caen, Lyon, Paris, Strasbourg, Toulouse
2026-12-14
Not yet open
Centre Hospitalier Universitaire de Saint Etienne
Phase 1/2
44
Amiens, Angers, Annecy, Argenteuil, Bayonne, Bordeaux, Brest, Caen
2026-12-01
Not yet open
Brain Iron in Beta-Propeller Protein Associated Neurodegeneration (BPAN)
NCT07868120Neurodegeneration With Brain Iron Accumulation (NBIA), Iron Metabolism Disorders, Brain Disease
University Hospital, Bordeaux
Not applicable
3
Bordeaux
2026-12
Not yet open
University Hospital, Bordeaux
Observational
1,000
Bordeaux
2026-12
Not yet open
Impact of a Radiologic and Immunologic Signature on Cerebral Efficacy of Treatments in Lung Cancers With Brain Metastasis
NCT07904013Carcinoma, Non-Small-Cell Lung, Brain Neoplasms, Neoplasm Metastasis
University Hospital, Bordeaux
Observational
38
Bordeaux
2026-12
Not yet open
The Lymphoma Academic Research Organisation
Phase 2
95
Lyon, Argenteuil, Avignon, Bayonne, Bordeaux, Cergy-Pontoise, Corbeil-Essonnes, Estaing
2026-12
Not yet open
Prognostic and Predictive Factors in Childhood Soft Tissue Sarcomas
NCT07924384Non-rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS)
Institut Curie
Observational
150
Saint-Denis, Amiens, Angers, Besançon, Bordeaux, Brest, Caen, Clermont-Ferrand
2026-12
Not yet open
Validation Of anatomY-specific Aortic Valve Implantation Guided by Software Using EncantoR
NCT07696182Severe Native Calcific Aortic Stenosis, Symptomatic Heart Disease Due to Severe Native Calcific Aortic Stenosis
Abbott Medical Devices
Not applicable
300
Bordeaux, Marseille, Massy, Rouen, Toulouse
2026-11-30
Not yet open
TicAgreLor Versus Placebo to Prevent Cerebral ISCHemia in anEuRysmal Low Grade SAH A Double Blinded Randomised Controlled Study
NCT07821008Subarachnoid Hemorrhage, Aneurysmal, Brain Ischemia, Endovascular Procedure
University Hospital, Toulouse
Phase 3
274
Bordeaux, Montpellier, Nantes, Paris, Strasbourg, Toulouse, Tours
2026-11-24
Not yet open
PharmaMar
Phase 1/2
231
Bordeaux, Lyon, Nice
2026-11-12
Recruiting
Vaderis Therapeutics AG
Phase 3
240
Angers, Bordeaux
2026-11-02
Not yet open
University Hospital, Bordeaux
Not applicable
100
Bordeaux
2026-11-01
Not yet open
Assistance Publique - Hôpitaux de Paris
Observational
1,000
Amiens, Angers, Bordeaux, Brest, Bron, Clermont-Ferrand, Dijon, Épagny
2026-11-01
Not yet open
Assistance Publique - Hôpitaux de Paris
Phase 3
150
Angers, Bordeaux, Brest, Caen, Clermont-Ferrand, Dijon, Grenoble, Le Kremlin-Bicêtre
2026-11-01
Not yet open
University Hospital, Toulouse
Not applicable
150
Bordeaux, Limoges, Montpellier, Paris, Toulouse
2026-11
Not yet open
University Hospital, Clermont-Ferrand
Phase 3
1,600
Aix-en-Provence, Amiens, Argenteuil, Arras, Bordeaux, Brest, Caen, Clermont-Ferrand
2026-11
Not yet open
University Hospital, Angers
Phase 3
50
Angers, Besançon, Bordeaux, Bron, Dijon, La Tronche, Le Kremlin-Bicêtre, Lille
2026-11
Not yet open
iVascular S.L.U.
Not applicable
45
Bordeaux, Lille
2026-11
Recruiting
Faron Pharmaceuticals Ltd
Phase 2
90
Bordeaux, Paris, Poitiers, Villejuif
2026-11
Not yet open
iVascular S.L.U.
Not applicable
160
Bordeaux, Brest, Lille, Nancy, Paris, Strasbourg
2026-11
Not yet open
Best Salvage Treatment for High-risk Relapsing Prostate Cancer (PEACE-9 - ESCALATE-RT)
NCT07782112Prostatic Neoplasms, Biochemical Recurrence, Oligometastatic Prostate Cancer
Ente Ospedaliero Cantonale, Bellinzona
Phase 3
140
Bordeaux, Lille, Saint-Etienne, Saint-Herblain, Villejuif
2026-11
Recruiting
Takeda
Phase 2
36
Bordeaux, Créteil, Lyon, Toulouse
2026-10-27
Not yet open
Hospices Civils de Lyon
Not applicable
128
Bordeaux, Limoges, Lyon, Marseille, Paris, Tours
2026-10-22
Not yet open
University Hospital, Toulouse
Phase 4
160
Besançon, Bordeaux, Caen, Clermont-Ferrand, Créteil, Dijon, Grenoble, Libourne
2026-10-20
Recruiting
Fight Osteosarcoma Through European Research Evolving Study Platform From Diagnosis to Relapse
NCT07871864Osteosarcoma, Pediatric Osteosarcoma, Osteosarcoma in Children, Osteosarcoma in Adolescents and Young Adults
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3
530
Amiens, Angers, Besançon, Bordeaux, Brest, Caen, Dijon, Grenoble
2026-10-07
Recruiting
Bristol-Myers Squibb
Phase 3
176
Bordeaux, Bron, Paris
2026-10-06
Not yet open
University Hospital, Grenoble
Not applicable
987
Annecy, Bordeaux, Chambéry, La Roche-sur-Yon, Lyon, Nancy, Nantes, Rennes
2026-10-01
By invitation
Alterity Therapeutics
Phase 2
7
Toulouse, Bordeaux, Marseille, Paris
2026-10-01
Not yet open
GCS Ramsay Santé pour l'Enseignement et la Recherche
Not applicable
456
Bordeaux, Marseille, Mont-de-Marsan, Paris, Quint-Fonsegrives
2026-10
Not yet open
University Hospital, Montpellier
Phase 3
366
Amiens, Angers, Avignon, Besançon, Béziers, Bordeaux, Brest, Caen
2026-10
Not yet open
University Hospital, Strasbourg, France
Phase 1/2
89
Bordeaux, Lille, Lyon, Marseille, Nancy, Paris, Strasbourg, Toulouse
2026-10
Not yet open
University Hospital, Bordeaux
Not applicable
50
Bordeaux
2026-09-30
Recruiting
Corbus Pharmaceuticals Inc.
Phase 3
260
Saint-Herblain, Montpellier, Paris, Bordeaux, Dijon, Lyon, Marseille
2026-09-29
Recruiting
ODSSEY-SCD_Identification Of Markers to preDict the rISk of Sudden Cardiac Death in Moderated LVEF in ischEmic cardiomyopathY
NCT07545512Myocardial Infarction (MI), Sudden Cardiac Death Due to Cardiac Arrhythmia
University Hospital, Clermont-Ferrand
Not applicable
400
Amiens, Bordeaux, Brest, Caen, Clermont-Ferrand, Lille, Lyon, Nancy
2026-09-24
Not yet open
Assessment of Information Provided on Infectious Risk in Solid Organ Transplantation
NCT07788417Transplantation Infection, Pulmonary Transplantation
Fondation Hôpital Saint-Joseph
Observational
1,000
Paris, Bordeaux, Lyon, Marseille, Nantes, Strasbourg, Suresnes
2026-09-15
Recruiting
Institut Bergonié
Not applicable
70
Bordeaux
2026-09-15
Recruiting
Incyte Corporation
Phase 3
426
Amiens, Bordeaux, Brest, Créteil, Le Kremlin-Bicêtre, Nice, Paris, Poitiers
2026-09-08
Recruiting
Is Craving a Central Criterion for Diagnosing a Behavioral Addiction?
NCT07854912Addictive Behaviors, Internet Addiction Disorder, Gambling, Technology Addiction
University of Bordeaux
Observational
150
Bordeaux
2026-09-02
Not yet open
Morphology in Oral Rare Syndromes & Artificial Intelligence for Clinical Diagnosis
NCT07666269Osteogenesis Imperfecta, Rare Bone Disorders, Hypophosphatemia, X-Linked
University Hospital, Bordeaux
Not applicable
240
Bordeaux
2026-09-01
Not yet open
Fondation Hôpital Saint-Joseph
Not applicable
2,400
Angers, Bobigny, Bordeaux, Clermont-Ferrand, Dijon, Le Plessis-Robinson, Lille, Lyon
2026-09-01
Not yet open
University Hospital, Bordeaux
Observational
30
Bordeaux
2026-09-01
Not yet open
University Hospital, Toulouse
Phase 3
724
Bordeaux, Grenoble, Lille, Limoges, Marseille, Montpellier, Nantes, Paris
2026-09-01
Not yet open
University Hospital, Toulouse
Phase 2
25
Bordeaux, Montpellier, Paris, Toulouse
2026-09-01
Not yet open
Superior Mesenteric Artery First Versus Standard Approach in Pancreaticoduodenectomy
NCT07547033Pancreatic Adenocarcinoma, Pancreatic Head Cancer
Assistance Publique - Hôpitaux de Paris
Not applicable
150
Amiens, Angers, Besançon, Bordeaux, Clermont-Ferrand, Dijon, Lille, Limoges
2026-09-01
Not yet open
Centre Hospitalier Universitaire de Nīmes
Phase 1/2
60
Bordeaux, Le Grau-du-Roi, Marseille, Toulouse, Tourcoing, Villeneuve-Saint-Georges
2026-09-01
Not yet open
University Hospital, Bordeaux
Phase 3
230
Bordeaux
2026-09
Not yet open
University of Bordeaux
Observational
160
Bordeaux
2026-09
Not yet open
University Hospital, Bordeaux
Phase 2
120
Bordeaux, Dijon, Lyon, Marseille, Montreuil, Nantes, Paris, Toulouse
2026-09
Not yet open
University Hospital, Bordeaux
Not applicable
304
Bordeaux, Paris
2026-09
Not yet open
Carboplatin-Enhanced Therapy in BRCA-Mutated or Neuroendocrine-Differentiated Aggressive Metastatic Castration-Sensitive Prostate Cancer
NCT07591467BRCA-Mutated, Neuroendocrine-Differentiated Aggressive Metastatic Castration-Sensitive Prostate Cancer, Prostate Cancer
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3
330
Bordeaux, Lyon, Marseille, Nancy, Villejuif
2026-09
Recruiting
AstraZeneca
Phase 3
1,072
Bordeaux, Nantes, Paris, Poitiers, Rennes, Strasbourg, Toulouse
2026-08-31
Recruiting
Institut du Cancer de Montpellier - Val d'Aurelle
Not applicable
96
Bordeaux, Montpellier
2026-08-28
Recruiting
University Hospital, Bordeaux
Not applicable
100
Bordeaux
2026-08-28
Recruiting
UNICANCER
Phase 2
275
Bordeaux, Boulogne-Billancourt, Nice, Villejuif
2026-08-21
Recruiting
University Hospital, Limoges
Not applicable
187
Bordeaux, Le Chesnay, Lille, Limoges, Poissy, Poitiers, Rennes
2026-08-05
Recruiting
Real-World Effectiveness and Safety of Pegcetacoplan in Patients With C3G or IC-MPG: A Multi-Country Study
NCT07746895C3 Glomerulopathy (C3G), Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN)
Swedish Orphan Biovitrum
Phase 4
150
Bordeaux, Bron, Créteil, Lille, Marseille, Montpellier, Nantes, Paris
2026-08-05
Not yet open
ARCAGY/ GINECO GROUP
Phase 1/2
43
Bordeaux, Caen, Dijon, Lyon, Marseille, Montpellier, Pierre-Bénite, Rennes
2026-08
Recruiting
Boehringer Ingelheim
Phase 3
448
Bordeaux, Brest, Caen, Epagny Metz-Tessy, Marseille, Nantes, Paris, Rennes
2026-07-27
Recruiting
AGE Accumulation in Patients on Long-term Parenteral Nutrition
NCT07392801Chronic Intestinal Insufficiency, Advanced Glycation and Products, Parenteral Nutrition
University Hospital, Bordeaux
Not applicable
50
Bordeaux, Paris, Pessac
2026-07-22
Recruiting
Nantes University Hospital
Phase 2
142
Angers, Bordeaux, Brest, Dijon, Nantes, Paris, Rennes, Strasbourg
2026-07-16
Recruiting
AstraZeneca
Phase 3
915
Bordeaux, Montpellier, Paris, Pierre-Bénite, Poitiers, Strasbourg
2026-07-16
Not yet open
Assistance Publique - Hôpitaux de Paris
Observational
350
Argenteuil, Aulnay-sous-Bois, Bondy, Bordeaux, Boulogne-Billancourt, Bry-sur-Marne, Cergy-Pontoise, Clamart
2026-07-15
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
134
Bordeaux, Nantes, Lyon
2026-07-06
Recruiting
Skipping Hormone Therapy in Low-Risk Early Breast Cancer
NCT07661927Breast Cancer (Early Breast Cancer)
UNICANCER
Phase 2
700
Angers, Avignon, Bayeux, Bayonne, Bordeaux, Boulogne-sur-Mer, Brest, Briis-sous-Forges
2026-07-06
Recruiting
Lidocaine for Opioid Sparing in Vaso-occlusive Crisis of Sickle Cell Disease
NCT07274254Vaso-Occlusive Pain Episode in Sickle Cell Disease
Nantes University Hospital
Phase 3
104
Bordeaux, Lille, Marseille, Nantes, Orléans, Paris, Poitiers, Rouen
2026-07-03
Not yet open
University Hospital, Brest
Observational
400
Rouen, Besançon, Bordeaux, Boulogne-sur-Mer, Brest, Caen, Caluire-et-Cuire, Clermont-Ferrand
2026-07-01
Not yet open
Modeling the Early Stages of Autoimmunity Through the Study of Immunological Thrombocytopenic Purpura and Juvenile Lupus
NCT07680010Immune Thrombocytopenic Purpura ( ITP ), Systemic Lupus Erythematosus (SLE)
University Hospital, Bordeaux
Not applicable
105
Bordeaux, Toulouse
2026-07
Not yet open
Gustave Roussy, Cancer Campus, Grand Paris
Phase 2
24
Villejuif, Bordeaux
2026-07
Not yet open
UNICANCER
Phase 2/3
160
Angers, Bordeaux, Brest, Caen, Clermont-Ferrand, Dijon, Grenoble, Lille
2026-07
Not yet open
Pre-anesthetic Teleconsultations During Pregnancy
NCT07542197Pregnancy, Anesthesia, Satisfaction, Telemedicine
University Hospital, Bordeaux
Not applicable
250
Bordeaux
2026-06-30
Not yet open
NEURO - Prognostication Using Late Somatosensory Evoked - Potentials
NCT07506928Comatose, Prognosis, Critical Care
University Hospital, Bordeaux
Not applicable
50
Bordeaux
2026-06-30
Not yet open
Nantes University Hospital
Not applicable
448
Angers, Antibes, Bordeaux, Brest, Caen, Clermont-Ferrand, Colmar, Créteil
2026-06-30
Recruiting
Efficacy in Relapse Prevention: Psilocybin in Alcohol Use Disorder With Depressive Symptoms
NCT07638553Alcohol Use Disorder, Depressive Sympotoms, Psilocybin
Centre Hospitalier Universitaire de Nīmes
Phase 3
172
Bayonne, Besançon, Bordeaux, Brest, Bron, Nantes, Nîmes, Saint-Priest
2026-06-30
Recruiting
Optimising Adjuvant Chemotherapy Prescription in Young Patients With Hormone-dependent Breast Cancer Using Genomic Tests
NCT07106632Early Breast Cancer, Premenopausal Breast Cancer, HR+/HER2- Breast Cancer
UNICANCER
Phase 3
3,380
Auxerre, Avignon, Bayonne, Beauvais, Blois, Bobigny, Bordeaux, Bourg-en-Bresse
2026-06-26
Recruiting
University Hospital, Montpellier
Phase 2
94
Bordeaux, Lyon, Montpellier, Paris, Poitiers, Toulouse
2026-06-25
Recruiting
Hopital Foch
Phase 2
36
Besançon, Bordeaux, Caen, Lille, Paris, Suresnes
2026-06-24
Recruiting
GlaxoSmithKline
Phase 1/2
64
Bordeaux, Lyon, Villejuif
2026-06-22
Recruiting
Efficacy of 12-week Daytime Restricted Eating on Hepatic Steatosis of Obesity
NCT07378072MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease)
Nantes University Hospital
Not applicable
72
Angers, Bordeaux, Dijon, Lyon, Marseille, Montpellier, Nantes, Paris
2026-06-17
Not yet open
Assistance Publique - Hôpitaux de Paris
Phase 3
486
Aix-en-Provence, Besançon, Bordeaux, Brest, Bron, Caen, Corbeil-Essonnes, Créteil
2026-06-15
Not yet open
Liquid Biopsy in Early Colorectal Lesions
NCT07319104Colorectal Neoplasms, Precancerous Conditions, Adenocarcinoma of the Colon
University Hospital, Montpellier
Observational
1,000
Amiens, Bordeaux, Brest, Dijon, Limoges, Lyon, Montpellier, Nancy
2026-06-15
Recruiting
Pharming Technologies B.V.
Phase 2
140
Angers, Bordeaux, Lille, Nantes, Nice, Strasbourg
2026-06-12
Recruiting
French Minds Cohort: a French Longitudinal and Multimodal Cohort of Patients With Major Mood Disorders, Psychotic Disorders, Autism Spectrum Disorders, and Healthy Controls
NCT07881016Schizophrenia / Schizoaffective Disorder, First Episode Psychosis (FEP), Bipolar Disorder (BD), Major Depressive Disorder (MDD
Fondation FondaMental
Not applicable
3,000
Besançon, Bordeaux, Brest, Bron, Clermont-Ferrand, Colombes, Créteil, Grenoble
2026-06-11
Recruiting
Nantes University Hospital
Phase 3
422
Aix-les-Bains, Angers, Besançon, Bordeaux, Brest, Créteil, Dijon, Grenoble
2026-06-11
Recruiting
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
NCT07504458Acute Promyelocytic Leukemia (APL), Acute Promyelocytic Leukaemia, Acute Promyelocytic Leukemia With PML-RARA, Acute Promyelocytic Leukemia With t(15;17)(q24.1;q21.2); PML-RARA
Quetzal Therapeutics
Phase 3
150
Bordeaux, La Tronche, Nancy, Nice, Paris, Saint-Priest-en-Jarez, Strasbourg
2026-06-08
Recruiting
Alianza multidisciplinar para la investigación de los tumores genitourinarios -GUARD
Phase 3
320
Bayonne, Bordeaux, Brest, Créteil, Grenoble, Levallois-Perret, Lorient, Montpellier
2026-06-05
Recruiting
A Study of Lirafugratinib in Non-CCA Solid Tumors With FGFR2 Fusion or Rearrangement
NCT07359820FGFR2 Gene Fusion/Rearrangement, Other Solid Tumors, Adult
Elevar Therapeutics
Phase 2
30
Bordeaux, Dijon, Lyon, Paris
2026-06-04
Recruiting
Rhythm Diagnostic Systems
Not applicable
80
Angers, Bordeaux, Mont-de-Marsan, Nantes
2026-06-03
Not yet open
FEcal tranSplantation in HidradeniTIs suppuratiVA : a piLot Study
NCT07668713Hidradenitis Suppurativa (HS), Fecal Microbiota Transplantation (FMT)
University Hospital, Clermont-Ferrand
Phase 1
24
Bordeaux, Clermont-Ferrand, Lyon, Marseille, Montpellier, Rodez
2026-06-01
Not yet open
University Hospital, Brest
Not applicable
246
Angers, Bordeaux, Brest, Cholet, La Roche-sur-Yon, Lorient, Nantes, Paris
2026-06-01
Not yet open
University Hospital, Toulouse
Phase 2
117
Bordeaux, Montpellier, Toulouse
2026-06
Recruiting
Poitiers University Hospital
Not applicable
75
Bordeaux, Poitiers
2026-06
Recruiting
Assistance Publique Hopitaux De Marseille
Observational
75
Saint-Denis, Annecy, Bordeaux, Caen, Chambéry, Clermont-Ferrand, Dijon, Grenoble
2026-05-28
Recruiting
BeOne Medicines
Phase 3
1,056
Bordeaux, Lyon, Marseille, Montpellier, Rennes, SaintHerblain, Villejuif
2026-05-22
Recruiting
University of Bordeaux
Observational
700
Bordeaux
2026-05-20
Active, closed
Natural History of Andes Virus Infection
NCT07703579Andes Hantavirus
Assistance Publique - Hôpitaux de Paris
Observational
15
Bordeaux, Paris
2026-05-19
Recruiting
University Hospital, Bordeaux
Not applicable
506
Aire-sur-l'Adour, Arès, Bon-Encontre, Bordeaux, Castets Et Castillon, Caudebec-lès-Elbeuf, Creysse, Elbeuf
2026-05-19
Recruiting
Novartis Pharmaceuticals
Phase 1
24
Bordeaux, Saint-Herblain
2026-05-19
Recruiting
Takeda
Phase 2
222
Bordeaux, Garches, Le Kremlin-Bicêtre, Paris
2026-05-17
Recruiting
Groupe SantéCité SantéCité Enseignement-Recherche-Innovation (GCS SCERI)
Not applicable
156
Bordeaux, Sainte-Foy-lès-Lyon, Toulouse
2026-05-13
Recruiting
Incyte Corporation
Phase 1
218
Bordeaux, Paris, Villejuif
2026-05-11
Recruiting
Novo Nordisk A/S
Phase 3
5,610
Bayonne, Bordeaux, Brest, Chambray-lès-Tours, Cholet, La Rochelle, Le Chesnay, Le Coudray
2026-05-11
Recruiting
Impact of Endotest on Patients' Quality of Life: a Cohort Study
NCT07560852Patient With a Prescribed Endotest, Endometriosis (Diagnosis)
ZIWIG
Observational
20,000
Bordeaux, Saint-Grégoire, Lorient, Peltre, Saint-Priest-en-Jarez, Pau, Montivilliers
2026-05-06
Recruiting
EMD Serono Research & Development Institute, Inc.
Phase 3
1,020
Marseille, Caen, Bordeaux, Lille, Saint Priest En Jarez, Lyon, Villejuif, Paris
2026-05-06
Recruiting
Initiatives Bronchopneumopathie Chronique Obstructive (BPCO)
Observational
500
Bordeaux, Lille, Nancy, Paris, Reims, Saint-Etienne
2026-05-01
Recruiting
Portal Therapeutics, Inc.
Observational
50
Bordeaux, Paris
2026-04-30
Recruiting
Assistance Publique Hopitaux De Marseille
Observational
675
Bordeaux, Lyon, Marseille, Nantes, Paris, Toulouse
2026-04-29
Recruiting
Calcium Isotope Ratios to Assess Calcium Bone Balance in Dialysis Children Receiving Cinacalcet
NCT07007338Children Over 3 Undergoing Dialysis With Secondary Hyperparathyroidism
Hospices Civils de Lyon
Observational
20
Bordeaux, Bron, Montpellier, Nice, Paris, Strasbourg
2026-04-29
Recruiting
University Hospital, Bordeaux
Not applicable
250
Bordeaux
2026-04-27
Recruiting
Alkermes, Inc.
Phase 3
176
Bordeaux, Lyon, Montpellier
2026-04-22
Recruiting
University Hospital, Bordeaux
Not applicable
120
Bordeaux
2026-04-21
Recruiting
University Hospital, Bordeaux
Not applicable
230
Bordeaux, Clamart, Limoges, Montpellier
2026-04-17
Recruiting
University Hospital, Bordeaux
Observational
6,109
Bordeaux
2026-04-17
Recruiting
Remibrutinib Open Label Roll-over Post-trial Access Protocol
NCT07456891Indication of the Parent Protocol
Novartis Pharmaceuticals
Phase 3
650
Bordeaux, Brest, Montpellier, Paris, Pierre-Bénite, Rouen, Saint-Mandé
2026-04-16
Recruiting
ETOP IBCSG Partners Foundation
Phase 2
48
Angers, Bordeaux, Lyon, Marseille
2026-04-15
Recruiting
KHENERFIN Study: A Trial to Evaluate the Efficacy and Safety of Sonlicromanol in Primary Mitochondrial Diseases
NCT06451757Mitochondrial Diseases, Maternally Inherited Diabetes and Deafness (MIDD), Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-like Episodes (MELAS), Mitochondrial DNA tRNALeu(UUR) m.3243A<G Mutation
Khondrion BV
Phase 3
220
Bordeaux, Paris
2026-04-14
Recruiting
Boehringer Ingelheim
Phase 3
670
Angers, Bordeaux, Caen, Dijon, Nantes, Paris, Toulouse, Villefranche-sur-Saône
2026-04-13
Not yet open
University Hospital, Bordeaux
Phase 2
72
Besançon, Bordeaux, Limoges, Marseille, Montpellier, Nantes, Paris, Reims
2026-04-13
Recruiting
Sim&Cure
Not applicable
576
Angers, Bordeaux, Le Kremlin-Bicêtre, Marseille, Paris, Reims
2026-04-10
Recruiting
University Hospital, Toulouse
Observational
120
Bordeaux, Caen, Lille, Lyon, Marseille, Paris, Rennes
2026-04-07
Recruiting
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
400
Bordeaux, Bron, Paris
2026-04-07
Recruiting
Alkermes, Inc.
Phase 3
150
Bordeaux, Lyon, Montpellier
2026-04-06
Recruiting
Intergroupe Francophone de Cancerologie Thoracique
Phase 2
126
Aix-en-Provence, Amiens, Angers, Avignon, Besançon, Bordeaux, Boulogne-Billancourt, Caen
2026-04-02
Not yet open
University Hospital, Tours
Phase 4
200
Amiens, Bordeaux, Chambray-lès-Tours, Créteil, Dijon, La Tronche, Le Mans, Lille
2026-04-01
Not yet open
Assistance Publique - Hôpitaux de Paris
Observational
350
Bordeaux, Clamart, Clermont-Ferrand, Le Kremlin-Bicêtre, Lille, Lyon, Martigues, Nancy
2026-04-01
Not yet open
University Hospital, Bordeaux
Not applicable
4,200
Bordeaux
2026-04
Recruiting
University Hospital, Bordeaux
Observational
500
Angers, Bordeaux, Caen, Libourne, Pessac, Toulon, Trévenans
2026-03-31
Recruiting
Veno-arterial Carbon Dioxide Partial Pressure Difference (CO2gap) for Early Resuscitation of Septic Shock
NCT07179276Sepsis - to Reduce Mortality in the Intensive Care Unit, Septic Shock
University Hospital, Clermont-Ferrand
Not applicable
750
Angers, Aurillac, Bayonne, Bordeaux, Clermont-Ferrand, Dijon, Grenoble, Le Puy-en-Velay
2026-03-29
Recruiting
AstraZeneca
Phase 2
43
Bordeaux, Créteil, Lyon, Nantes, Nîmes
2026-03-28
Recruiting
A 2-part Phase 1/2 Open-label Trial on ODM-212
NCT07563738Mesothelioma, Pancreatic Cancer, NSCLC (Advanced Non-small Cell Lung Cancer)
Orion Corporation, Orion Pharma
Phase 1/2
229
Bordeaux, Marseille, Poitiers, Villejuif
2026-03-27
Recruiting
Understanding of Rare Inflammatory Arthritis in Comparison to Classical Inflammatory Arthritis : Tissular Observations and Immune Infiltrate Characterization : the UTOPIC Project
NCT07302074Inflammatory Arthritis, Rare Auto-immune Diseases, Immune Checkpoint Inhibitor Related Inflamamtory Arthritis
University Hospital, Brest
Not applicable
100
Bordeaux, Brest
2026-03-27
Recruiting
Institut Bergonié
Observational
50
Bordeaux
2026-03-27
Recruiting
Gustave Roussy, Cancer Campus, Grand Paris
Phase 2
60
Villejuif, Bordeaux, Dijon, Marseille, Paris, Saint-Herblain, Vandœuvre-lès-Nancy
2026-03-25
Recruiting
University Hospital, Tours
Observational
149
Angers, Bordeaux, Brest, Dijon, Grenoble, Lille, Lyon, Marseille
2026-03-23
Recruiting
Boehringer Ingelheim
Phase 2
132
Amiens, Bordeaux, Créteil, Nice, Paris
2026-03-23
Recruiting
Centre Hospitalier de PAU
Observational
1,000
Annecy, Bordeaux, Chalon-sur-Saône, Lyon, Paris, Strasbourg, Toulouse, Tours
2026-03-19
Recruiting
SymBio Pharmaceuticals
Phase 3
180
Bordeaux, Lille, Nancy, Nantes, Paris, Rennes, Strasbourg
2026-03-17
Recruiting
Omnipod-5 A French Prospective Multicentric Study in Real World (Optimal-B)
NCT07317102Diabetes, Type 1 Diabetes, Diabetes Mellitus
Insulet Corporation
Observational
152
Angers, Besançon, Bobigny, Bordeaux, Brest, Bron, Corbeil-Essonnes, Dijon
2026-03-16
Recruiting
Parenting and CAH - 21-hydroxylase Deficiency
NCT06900153CAH - 21-Hydroxylase Deficiency
Assistance Publique - Hôpitaux de Paris
Observational
200
Bordeaux, Bron, Créteil, Le Kremlin-Bicêtre, Paris
2026-03-16
Recruiting
Bristol-Myers Squibb
Phase 3
850
Bordeaux, Lyon Cedex08, Dijon, Montpellier, Saint-Herblain, Toulouse, Lille, Villejuif
2026-03-16
Recruiting
Impact of Capillaroscopy in the Investigation of Diffuse Interstitial Pneumonias
NCT07283081Interstitial Lung Disease, Connective Tissue Diseases
University Hospital, Bordeaux
Not applicable
48
Bordeaux
2026-03-16
Not yet open
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba
Observational
50
Argenteuil, Bordeaux, Garches, Levallois-Perret, Nantes, Nice, Paris, Tourcoing
2026-03-15
Recruiting
Efficacy and Tolerability of TENS in Endometriosis-related Pain
NCT07393295Pelvic Pain Associated With Endometriosis or Adenomyosis, Pelvic Pain Associated With Refractory Endometriosis, Endometriosis
Monath Electronic
Not applicable
92
Bordeaux
2026-03-15
Recruiting
Sanofi
Phase 2/3
526
Bordeaux, Nantes, Paris, Toulouse, Tours
2026-03-13
Recruiting
Centre Hospitalier Universitaire de Nice
Phase 2
56
Nice, Paris, Bordeaux, La Réunion, Lyon
2026-03-12
Recruiting
Multicenter Prospective Cohort on Esophageal Endoscopic Submucosal Dissection
NCT07343869Superficial Esophageal Cancer, Oesophageal Adenocarcinoma, Oesophageal Squamous Cell Carcinoma, Barretts Esophagus With Dysplasia
Société Française d'Endoscopie Digestive
Observational
750
Bordeaux, Limoges, Lyon, Nancy, Nantes, Rennes, Rouen
2026-03-11
Recruiting
Hoffmann-La Roche
Phase 2
100
Bordeaux, Villejuif, Lyon, Marseille
2026-03-11
Recruiting
Hoffmann-La Roche
Phase 2
360
Strasbourg, Nîmes, Bordeaux, Toulouse, Montpellier, Saint-Herblain, Nancy, Clermont-Ferrand
2026-03-10
Recruiting
Novartis Pharmaceuticals
Phase 2
210
Bordeaux, Brest, Créteil, Nice, Reims, Rouen, Toulouse
2026-03-09
Recruiting
Efficacy and Safety of the Valemetostat in Patients With Selected Solid Tumors.
NCT07303387Solid Tumor Malignancies, Clear Cell Endometrial Carcinoma, Ovarian Cancer
Gustave Roussy, Cancer Campus, Grand Paris
Phase 2
900
Villejuif, Bordeaux, Lyon, Paris
2026-03-05
Recruiting
Incyte Corporation
Phase 3
700
Angers, Bordeaux, Marseille, Paris, Poitiers, Reims, Saint-Etienne, Toulouse
2026-03-05
Recruiting
Alpha Radiation Emitters Device (DaRT) for the Treatment of Locally Advanced Pancreatic Cancer
NCT06755359Pancreatic Cancer, Locally Advanced Pancreatic Cancer
Alpha Tau Medical LTD.
Not applicable
40
Bordeaux, Clermont-Ferrand, Dijon, Grenoble, Lyon, Marseille, Poitiers, Villejuif
2026-03-01
Not yet open
Assistance Publique - Hôpitaux de Paris
Not applicable
208
Amiens, Bordeaux, Caen, Clamart, Colombes, Créteil, Grenoble, Le Kremlin-Bicêtre
2026-03-01
Not yet open
University Hospital, Toulouse
Phase 3
130
Amiens, Angers, Besançon, Bordeaux, Boulogne-sur-Mer, Brest, Caen, Grenoble
2026-03-01
Not yet open
Occupational Exposure to Antineoplastic Drugs Among Physiotherapists in Healthcare Settings
NCT07328464Internal and External Contamination of Physiotherapists by Antineoplastic Drugs
Assistance Publique Hopitaux De Marseille
Observational
20
Bordeaux, Marseille
2026-03
Recruiting
Mirum Pharmaceuticals, Inc.
Phase 2/3
120
Bordeaux, Clermont-Ferrand, Clichy, Créteil, Grenoble, Lille, Limoges, Lyon
2026-02-26
Recruiting
Astellas Pharma Global Development, Inc.
Phase 3
614
Bordeaux, Brest, Caen, Grenoble, Paris, Toulouse, Vandœuvre-lès-Nancy, Villejuif
2026-02-17
Recruiting
iVascular S.L.U.
Not applicable
165
Bordeaux, Brest, Lille, Marseille, Nîmes, Toulouse, Villeneuve-d'Ascq
2026-02-16
Recruiting
Boehringer Ingelheim
Phase 3
286
Amiens, Bordeaux, Brest, Créteil, Lyon, Nice, Nîmes, Paris
2026-02-16
Recruiting
ViiV Healthcare
Phase 2
186
Bordeaux, Caen, Nantes, Nîmes, Paris
2026-02-11
Recruiting
GlaxoSmithKline
Phase 1
44
Bordeaux, Toulouse
2026-02-10
Recruiting
AstraZeneca
Phase 3
2,130
Bordeaux, Caen, Lyon, Marseille, Rennes, Villejuif
2026-02-03
Recruiting
Nantes University Hospital
Observational
1,000
Bordeaux, Brest, Clermont-Ferrand, Dijon, La Rochelle, Limoges, Montpellier, Nantes
2026-02-03
Recruiting
Neuravi Limited
Not applicable
74
Bordeaux, Nantes, Paris, Toulouse, Tours
2026-02-02
Recruiting
BosSTENT ImpLant to trEat debilitatiNg Pulse-synchronous Tinnitus
NCT07070089Pulsatile Tinnitus, Venous Sinus Stenosis
Sonorous NV, Inc
Not applicable
90
Bordeaux, Montpellier, Paris, Tours
2026-02-01
Not yet open
University Hospital, Bordeaux
Not applicable
150
Bordeaux
2026-02
Not yet open
Implementation of Long-read Sequencing for the Diagnosis of Rare Diseases.
NCT07400913Rare Diseases, Albinism, Intellectual Disability
University Hospital, Bordeaux
Observational
150
Bordeaux
2026-02
Recruiting
Tucatinib and Trastuzumab in HER3-mutant and HER2-not Amplified Metastatic Breast Cancer
NCT07193394Metastatic Breast Cancer ( HER2 Negative), Unresectable Breast Cancer
Institut Curie
Phase 2
20
Bordeaux, Limoges, Marseille, Nice, Nîmes, Rennes, Saint-Cloud, Toulouse
2026-01-31
Recruiting
T.O.A.D. Oncology SA
Phase 1/2
180
Bordeaux, Paris, Villejuif
2026-01-30
Recruiting
Assistance Publique - Hôpitaux de Paris
Phase 2
30
Blois, Bondy, Bordeaux, Caen, Clermont-Ferrand, Créteil, Dijon, Le Kremlin-Bicêtre
2026-01-30
Recruiting
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
NCT07227298Advanced/Metastatic Non-Small Cell Lung Cancer, Carcinoma, Non-Small Cell Lung, Non-Small Cell Lung Cancer
Pfizer
Phase 1/2
162
Bordeaux, Dijon, Marseille, Paris
2026-01-30
Recruiting
IDEAYA Biosciences
Phase 3
520
Nice, Bordeaux, Rennes, Paris
2026-01-25
Recruiting
BeOne Medicines
Phase 3
500
Bordeaux, ClermontFerrand, Le Mans, Lille, Lyon, Montpellier, Toulouse
2026-01-22
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,023
Strasbourg, Pierre-Bénite, Brest, Caen, Chambray-lès-Tours, Bordeaux, Toulouse, Paris
2026-01-19
Recruiting
Vorasidenib Maintenance for IDH Mutant Astrocytoma
NCT06809322IDH-mutant Grade 2 or 3 Astrocytoma
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
468
Bordeaux, Lyon, Marseille, Paris, Toulouse
2026-01-16
Recruiting
University Hospital, Bordeaux
Not applicable
50
Bordeaux
2026-01-15
Recruiting
Central Hospital, Nancy, France
Phase 3
60
Besançon, Bordeaux, Brest, Caen, Clermont-Ferrand, Colmar, Grenoble, Lille
2026-01-15
Recruiting
Neo-adjuvant Immunotherapy in Patients With Localized Melanoma
NCT07230613Cutaneous Melanoma, Stage III, Mucosal Melanoma
UNICANCER
Phase 2
50
Bordeaux, Lyon, Marseille, Paris, Villejuif
2026-01-12
Recruiting
Rennes University Hospital
Phase 3
532
Angers, Bordeaux, Brest, Caen, Dijon, Grenoble, Lille, Marseille
2026-01-07
Recruiting
Biogen
Phase 2
81
Bordeaux, La Tronche, Lyon, Toulouse
2026-01-05
Recruiting
Institut Curie
Not applicable
450
Avignon, Bordeaux, Clermont-Ferrand, Lyon, Marseille, Montpellier, Nîmes, Paris
2026-01-05
Not yet open
Centre Hospitalier le Mans
Observational
1,111
Angers, Bordeaux, Brest, Caen, Le Mans, Lorient, Metz, Nancy
2026-01-01
Not yet open
University Hospital, Grenoble
Not applicable
110
Bordeaux, Clermont-Ferrand, Grenoble, Saint-Etienne
2026-01-01
Not yet open
Fungal Vascular Graft Infections, French Multicenter Retrospective Study
NCT07143409Fungal Infection, Vascular Grafting
University Hospital, Bordeaux
Observational
300
Bordeaux
2026-01
Not yet open
University Hospital, Bordeaux
Observational
450
Amiens, Bois-Guillaume, Bordeaux, Caen, Créteil, Grenoble, Lille, Lyon
2026-01
Not yet open
University Hospital, Bordeaux
Observational
100
Bordeaux
2026-01
Not yet open
Vascular Infections Caused by Coxiella Burnetii
NCT07305402Vascular Infection Caused by C. Burnetii
University Hospital, Bordeaux
Observational
400
Bordeaux
2026-01
Not yet open
University Hospital, Toulouse
Phase 2
50
Bordeaux, Dijon, Montpellier, Nantes, Toulouse
2026-01
Not yet open
Prevalence of Alpha-1 Antitrypsin Deficiency in Non-Cirrhotic Liver Cancer
NCT07145385Retrospective Cohort of Patients Diagnosed With HCC on Non-Cirrhotic Liver
University Hospital, Bordeaux
Observational
71
Bordeaux
2026-01
Recruiting
AEF0217 in Participants With Down Syndrome
NCT07334912Down Syndrome (Trisomy 21)
Aelis Farma
Phase 2
188
Bordeaux, Lyon, Montpellier, Paris, Saint-Etienne
2025-12-22
Recruiting
Regeneron Pharmaceuticals
Phase 1
90
Bordeaux
2025-12-22
Recruiting
Taiho Oncology, Inc.
Phase 3
360
Bordeaux, Bron, Lyon, Pierre-Bénite, Villefranche-de-Rouergue, Caen, Nîmes, Mulhouse
2025-12-22
Active, closed
Amgen
Phase 3
250
Angers, Bordeaux, Grenoble, Montpellier, Pierre-Bénite
2025-12-19
Recruiting
Janssen Research & Development, LLC
Phase 3
800
Bordeaux, Clermont-Ferrand, Lille, Lyon, Nîmes, Paris, Rennes, Villejuif
2025-12-19
Recruiting
Post-market Clinical Follow-up Study of NEMOST V2
NCT07403084Scoliosis Neuromuscular, Scoliosis Idiopathic, Consent Forms
EUROS
Not applicable
140
Nice, Bordeaux, Lyon, Paris
2025-12-19
Recruiting
Merck Sharp & Dohme LLC
Phase 2/3
570
Bordeaux, Toulouse, Nantes, Lyon, Bobigny, Paris
2025-12-18
Recruiting
University Hospital, Brest
Phase 3
140
Aix-en-Provence, Arras, Besançon, Bordeaux, Brest, Caen, Cholet, Clermont-Ferrand
2025-12-18
Recruiting
Centre Hospitalier Universitaire de Saint Etienne
Phase 4
1,052
Saint-Etienne, Annecy, Besançon, Bordeaux, Brest, Chambéry, Créteil, Dijon
2025-12-17
Recruiting
Federation Francophone de Cancerologie Digestive
Phase 3
324
Aurillac, Avignon, Bayeux, Bayonne, Bezannes, Bordeaux, Brest, Caen
2025-12-15
Recruiting
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
NCT07218380Carcinoma, Transitional Cell, Urinary Bladder Neoplasms, Neoplasm Metastasis
Eli Lilly and Company
Phase 3
450
Angers, Bordeaux, Brest, Caen, Lille, Lyon Cedex08, Marseille, Nîmes
2025-12-12
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
1,000
Angers, Bordeaux, Brest, Lille, Lyon, Marseille, Paris, Strasbourg
2025-12-11
Recruiting
Incidence of Depression and Its Complications After Surgical Site Infection - ISODEP.
NCT07125196Surgical Site Infections, Depression, Malnutrition
University Hospital, Bordeaux
Not applicable
300
Bordeaux
2025-12-11
Recruiting
mylife Diabetes Care AG
Observational
125
Amiens, Angers, Argenteuil, Bois-Guillaume, Bordeaux, Brest, Bron, Grenoble
2025-12-11
Recruiting
ALX Oncology Inc.
Phase 2
120
Besançon, Bordeaux, Paris, Poitiers, Rennes, Villejuif
2025-12-10
Recruiting
Intergroupe Francophone de Cancerologie Thoracique
Phase 3
133
Besançon, Bordeaux, Brest, Caen, Créteil, Dijon, Grenoble, La Roche-sur-Yon
2025-12-09
Recruiting
University Hospital, Bordeaux
Not applicable
300
Angers, Bayonne, Bordeaux, Brest, Créteil, La Roche-sur-Yon, Le Kremlin-Bicêtre, Libourne
2025-12-09
Recruiting
Incyte Corporation
Phase 3
466
Avignon, Bordeaux, Chambray-lès-Tours, La Roche-sur-Yon, La Tronche, Lyon, Marseille, Nice
2025-12-09
Recruiting
Autonomous Methadone Delivery System by Nurses
NCT07085377Opioid Use Disorder (OUD), Addictology
Hospices Civils de Lyon
Not applicable
182
Bayonne, Bordeaux, Brioude, Le Puy-en-Velay, Lyon, Strasbourg, Villeurbanne
2025-12-08
Recruiting
A Phase Ib/II Open-label Study of AMO959 With Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI in Adult Participants With PSMA-positive mCRPC
NCT07226986PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy
Novartis Pharmaceuticals
Phase 1/2
123
Bordeaux, Clermont-Ferrand, Nantes, Villejuif
2025-12-05
Recruiting
University Hospital, Bordeaux
Observational
150
Bordeaux
2025-12-04
Recruiting
GlaxoSmithKline
Phase 3
450
Angers, Bordeaux, Lille, Lyon, Marseille, Saint-Herblain, Toulouse, Villejuif
2025-12-03
Recruiting
University Hospital, Bordeaux
Not applicable
265
Bordeaux
2025-12-03
Not yet open
University Hospital, Toulouse
Not applicable
178
Bordeaux, Lille, Marseille, Montpellier, Paris, Quint-Fonsegrives, Toulouse
2025-12-01
Not yet open
French Innovative Leukemia Organisation
Phase 2
102
Amiens, Angers, Annecy, Argenteuil, Bayonne, Besançon, Bordeaux, Caen
2025-12-01
Not yet open
Impact of Ambulatory Management for Primary Spontaneous Pneumothorax in the Emergency Department on Quality of Life
NCT06471608Primary Spontaneous Pneumothorax, Quality of Life, Ambulatory Care, Chest Tube
University Hospital, Strasbourg, France
Not applicable
386
Besançon, Bordeaux, La Tronche, Paris, Poitiers, Strasbourg
2025-12-01
Not yet open
Effect of G-CSF on MDSC and Cancer Stem-cells Interactions in Non-small Cell Lung Cancers (CIRCUIT)
NCT06711770Non Small Cell Lung Cancer, Immunotherapy, Granulocyte Colony Stimulating Factor
University Hospital, Bordeaux
Not applicable
30
Bordeaux
2025-12
Not yet open
Role of MDSCs and Cancer Stem Cells and Their Cross Talks in NSCLC
NCT06024226Lung Neoplasms, Myeloid-Derived Suppressor Cells, Immunosuppression
University Hospital, Bordeaux
Observational
10
Bordeaux
2025-12
Not yet open
Role of Cancer-associated Fibroblast, MDSCs and Immune Cell Interplays in the Resistance of Non-small Cell Lung Cancer to Anti-PD1/PD-L1 Therapies
NCT06024538Lung Neoplasm, Cancer Associated Fibroblast, Myeloid-Derived Suppressive Cells Immunosuppression
University Hospital, Bordeaux
Observational
25
Bordeaux
2025-12
Recruiting
University Hospital, Tours
Not applicable
1,078
Amiens, Angers, Argenteuil, Belfort, Besançon, Béthune, Blois, Bordeaux
2025-11-30
Recruiting
Genmab
Phase 3
660
Clermont-Ferrand, Grenoble, Strasbourg, Dijon, Brest, Bordeaux, Orléans, Reims
2025-11-28
Recruiting
Amgen
Phase 3
750
Bordeaux, Caen, Clermont-Ferrand, Le Mans, Lyon, Nice, Paris, Strasbourg
2025-11-28
Recruiting
Merck Sharp & Dohme LLC
Phase 3
904
Bordeaux, Suresnes, Montpellier, La Tronche, Nancy, Angers, Bayonne, Pierre-Bénite
2025-11-26
Active, closed
Amgen
Phase 3
250
Angers, Bordeaux, Grenoble
2025-11-25
Recruiting
A Platform Study in Non-Small Cell Lung Cancer (NSCLC)
NCT06996782Advanced or Metastatic Non-small Cell Lung Cancer
AstraZeneca
Phase 1/2
152
Bordeaux, Dijon, Limoges, Marseille, Nantes, Nice, Paris
2025-11-24
Recruiting
Summit Therapeutics
Phase 3
900
Bordeaux, Lille, Lyon, Marseille, Montpellier, Nancy, Nantes, Nice
2025-11-18
Recruiting
UNICANCER
Phase 2/3
196
Bordeaux, Clichy, Dijon, Marseille, Montpellier, Nantes, Paris, Poitiers
2025-11-14
Recruiting
University Hospital, Bordeaux
Not applicable
100
Bordeaux, Montpellier, Paris
2025-11-13
Recruiting
Incyte Corporation
Phase 3
250
Argenteuil, Bordeaux, Créteil, Lyon, Nantes, Nice, Paris, Reims
2025-11-13
Active, closed
Hoffmann-La Roche
Phase 3
1,060
Amiens Cedex1, Bordeaux, Bron, Limoges, Montpellier, Paris, Saint-Herblain, Strasbourg
2025-11-12
Recruiting
Nantes University Hospital
Not applicable
686
Angers, Angoulème, Argenteuil, Nantes, Arles, Avignon, Belfort, Bordeaux
2025-11-11
Recruiting
University Hospital, Bordeaux
Not applicable
60
Amiens, Bordeaux, Limoges, Paris, Rouen
2025-11-10
Recruiting
Sanofi
Phase 2
208
Antony, Bezannes, Bordeaux, Lyon, Saint-Priest-en-Jarez, Toulouse
2025-11-06
Recruiting
AbbVie
Phase 3
561
Nice, Lyon, Bordeaux, Nantes, Écully, Créteil, Marseille, Paris
2025-11-05
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
1,200
Aix-en-Provence, Bordeaux, Bourg-en-Bresse, Brest, Caen, Dieppe, Fréjus, Garches
2025-11-05
Recruiting
Centre Leon Berard
Phase 1/2
70
Angers, Bordeaux, Bron, Lille, Lyon, Marseille, Paris, Toulouse
2025-11-04
Active, closed
L'Oreal
Not applicable
239
Aix-en-Provence, Bordeaux, Tours, Villeurbanne
2025-11-04
Active, closed
Takeda
Phase 2
207
Bordeaux, Créteil, Le Mans, Martigues, Nice, Toulouse
2025-11-03
Recruiting
Takeda
Observational
10
Brest, Bordeaux, Montpellier, La Tronche, Créteil
2025-11-03
Recruiting
Novartis Pharmaceuticals
Phase 2
30
Bordeaux, Bron, Le Kremlin-Bicêtre, Lille, Paris
2025-11-03
Recruiting
Penumbra Inc.
Observational
200
Bordeaux, Brest, Toulouse
2025-11-01
Recruiting
Vocal Biomarkers of Craving
NCT07878624Addiction
University of Bordeaux
Observational
120
Bordeaux
2025-10-28
Recruiting
Assistance Publique - Hôpitaux de Paris
Phase 3
348
Bordeaux, Bron, Garches, Le Kremlin-Bicêtre, Lille, Marseille, Nancy, Paris
2025-10-28
Recruiting
Daiichi Sankyo
Phase 3
686
Angers, Bordeaux, Boulogne-Billancourt, Bron, Créteil, Dijon, Lille, Lyon
2025-10-24
Recruiting
Eli Lilly and Company
Phase 3
1,630
Angers, Bayonne, Besançon, Bordeaux, Brest, Lille, Limoges, Lyon Cedex08
2025-10-22
Recruiting
University Hospital, Bordeaux
Observational
45
Bordeaux
2025-10-22
Recruiting
Assistance Publique - Hôpitaux de Paris
Phase 3
70
Angers, Bordeaux, Dijon, Lyon, Montpellier, Paris, Rouen, Strasbourg
2025-10-21
Recruiting
Institut Claudius Regaud
Not applicable
130
Angers, Bordeaux, Caen, Lille, Lyon, Marseille, Montpellier, Paris
2025-10-21
Recruiting
A Study of Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thrombocytopenia (ITP)
NCT07194850Immune Thrombocytopenia (ITP), ITP - Immune Thrombocytopenia, ITP, Immune Thrombocytopenic Purpura
argenx
Phase 2/3
24
Bordeaux, La Tronche, Vandœuvre-lès-Nancy
2025-10-20
Recruiting
A Non-interventional Study of Participants With BPDCN Treated With Chemotherapy
NCT07785180Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Stemline Therapeutics, Inc.
Observational
140
Besançon, Bobigny, Bordeaux, Créteil, Nice, Paris, Poitiers, Tours
2025-10-17
Recruiting
Centre Hospitalier Charles Perrens, Bordeaux
Not applicable
200
Bordeaux
2025-10-13
Recruiting
Centre Hospitalier Universitaire de Nīmes
Not applicable
300
Bordeaux, Lyon, Nîmes
2025-10-10
Recruiting
UNICANCER
Phase 2
72
Amiens, Angers, Avignon, Besançon, Bordeaux, Caen, Clermont-Ferrand, Clichy
2025-10-09
Recruiting
Determinants of the Response to BTK Degraders (BTKd) in Chronic Lymphocytic Leukemia
NCT07099443Chronic Lymphocytic Leukemia, BTK Degraders
Nantes University Hospital
Observational
60
Angers, Bordeaux, Clermont-Ferrand, La Roche-sur-Yon, Lyon, Marseille, Montpellier, Nancy
2025-10-09
Recruiting
Bristol-Myers Squibb
Observational
223
Bordeaux, Strasbourg, Paris
2025-10-08
Recruiting
UNICANCER
Not applicable
724
Arras, Beuvry, Bordeaux, Caen, Chambray-lès-Tours, Clermont-Ferrand, Créteil, Dechy
2025-10-07
Recruiting
University Hospital, Toulouse
Phase 4
200
Amiens, Bordeaux, Cahors, Dax, Le Mans, Lille, Limoges, Marseille
2025-10-02
Not yet open
Hospices Civils de Lyon
Not applicable
316
Angers, Bordeaux, Epagny METZ Tessy, La Tronche, Lyon, Pierre-Benité, Toulon
2025-10-01
Active, closed
Hospices Civils de Lyon
Phase 2
27
Angers, Bordeaux, Bron, Lille, Lyon, Marseille, Montpellier, Paris
2025-10-01
Recruiting
HEM-iSMART-C: Ruxolitinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
NCT05745714Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Refractory
Princess Maxima Center for Pediatric Oncology
Phase 1/2
26
Bordeaux, Lille, Lyon, Marseille, Nantes, Paris
2025-10-01
Recruiting
HEM-iSMART-B: Dasatinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
NCT05751044Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Refractory
Princess Maxima Center for Pediatric Oncology
Phase 1/2
26
Bordeaux, Lille, Lyon, Marseille, Nantes, Paris
2025-10-01
Recruiting
Natural History of Type 1 Interferonopathies: Insights From a European Cohort
NCT07040774Genetic Disease, Immune Dysfunction, Neurological Diseases or Conditions, Autoimmune Diseases
Imagine Institute
Observational
500
Angers, Ars-Laquenexy, Besançon, Bordeaux, Brest, Bron, Dijon, Gleizé
2025-10-01
Not yet open
Assistance Publique - Hôpitaux de Paris
Observational
150
Amiens, Besançon, Bordeaux, Brest, Bron, Caen, Dijon, Grenoble
2025-10
Recruiting
Bristol-Myers Squibb
Phase 2/3
470
Nice, Strasbourg, Bordeaux, Lyon Cedex08, Brest, Suresnes, Saint-Herblain, Marseille
2025-09-30
Not yet open
University Hospital, Tours
Not applicable
80
Angers, Bayonne, Bordeaux, Chartres, Gradignan, La Roche-sur-Yon, Nantes, Orléans
2025-09-30
Recruiting
Teva Branded Pharmaceutical Products R&D LLC
Phase 2
200
Bordeaux, Marseille, Paris, Toulouse
2025-09-30
Recruiting
Pfizer
Phase 3
680
Brest, Toulouse, Rennes, Saint-Herblain, Lille, Villejuif, Bordeaux, Marseille
2025-09-29
Recruiting
Pfizer
Phase 3
1,000
Bordeaux, Lyon Cedex08, Brest, Besançon, Reims, Bayonne, Pierre-Bénite, Villejuif
2025-09-28
Recruiting
Daiichi Sankyo
Phase 2/3
630
Angers, Bordeaux, Brest, Calais, Cedex 10, Créteil, Grenoble, La Chaussée-Saint-Victor
2025-09-26
Recruiting
University Hospital, Rouen
Phase 3
188
Amiens, Beauvais, Besançon, Bicêtre, Bordeaux, Clermont-Ferrand, Lille, Marseille
2025-09-25
Recruiting
The Lymphoma Academic Research Organisation
Phase 2
60
Bordeaux, Caen, Clermont-Ferrand, Lille, Marseille, Nancy, Paris, Pierre-Bénite
2025-09-22
Recruiting
Clinique Tivoli Ducos
Not applicable
332
Bordeaux
2025-09-18
Recruiting
University Hospital, Bordeaux
Not applicable
30
Bordeaux
2025-09-16
Recruiting
University Hospital, Bordeaux
Not applicable
60
Bordeaux
2025-09-15
Active, closed
A Study to Test Whether Nerandomilast Helps People With Lung Fibrosis Related to Rheumatic Diseases
NCT06806592Interstitial Lung Diseases, Systemic Autoimmune Rheumatic Diseases Associated Interstitial Lung Diseases
Boehringer Ingelheim
Phase 3
414
Angers, Bordeaux, Lille, Paris, Rennes, Strasbourg, Toulouse
2025-09-13
Recruiting
University Hospital, Toulouse
Not applicable
692
Bordeaux, La Réunion, Poitiers, Toulouse
2025-09-09
Recruiting
Alnylam Pharmaceuticals
Phase 3
11,000
Auxerre, Bobigny, Bordeaux, Caen, Nîmes, Paris, Pau, Poitiers
2025-09-06
Recruiting
BeOne Medicines
Phase 3
500
Bordeaux, ClermontFerrand, Nantes, Paris, Rouen, Toulouse, Tours, VandoeuvrelesNancy
2025-09-04
Recruiting
Janssen Research & Development, LLC
Phase 3
1,203
Bordeaux, Brest, Dijon, Lille, Lyon, Paris, Pierre-Bénite, Saint-Herblain
2025-09-02
Recruiting
AbbVie
Observational
2,795
Dijon, Besançon, Bordeaux, Toulouse, Rennes, Chambray-lès-Tours, La Tronche, Lorient
2025-09-02
Not yet open
Community Screening and Management of Hepatitis B, C and Delta in the Mongolian Population Living in France
NCT07038863HEPATITIS C (HCV), Hepatitis B Virus (HBV), Hepatitis D, Hepatocellular Carcinoma (HCC)
Hospices Civils de Lyon
Not applicable
2,000
Annecy, Bordeaux, Clermont-Ferrand, Créteil, Grenoble, Lille, Lyon, Rennes
2025-09-01
Recruiting
Ustekinumab in BEhçet's Syndrome STudy
NCT07244614Behçet's Syndrome (BS)
Groupe français d'étude des Maladies Inflammatoires de loeil
Observational
208
Bordeaux, Créteil, Lyon, Melun, Paris, Rouen
2025-09-01
Not yet open
University Hospital, Bordeaux
Observational
100
Bordeaux
2025-09
Not yet open
Institut Bergonié
Phase 2
102
Bordeaux
2025-09
Not yet open
Low Powered Colorectal Anastomosis After Rectal Excision (OASIS)
NCT07146334Rectal Cancer, Surgery Indication
Bordeaux Colorectal Institute
Observational
400
Besançon, Bordeaux, Le Kremlin-Bicêtre, Lyon, Paris, Rouen
2025-09
Recruiting
Assessement of Effectiveness of Seawater Nasal Sprays on Sinonasal Symptoms
NCT07262450URTI, Bronchiolitis, COVID - 19, Allergic Rhinitis
Laboratoire de la Mer
Not applicable
1,065
Bordeaux, Bourg-la-Reine, Cabourg, Châteauroux, Châtenay-Malabry, Chevaigné, Clermont-Ferrand, Courrières
2025-08-27
Recruiting
Relay Therapeutics, Inc.
Phase 3
540
Angers, Besançon, Bobigny, Bordeaux, Caen, Dijon, Lyon, Marseille
2025-08-26
Recruiting
A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
NCT06920004Chronic Inflammatory Demyelinating Polyneuropathy, CIDP, CIDP - Chronic Inflammatory Demyelinating Polyneuropathy
argenx
Phase 3
218
Marseille, Paris, Bordeaux, Le Kremlin-Bicêtre, Nice, Strasbourg, Toulouse
2025-08-22
Recruiting
A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
NCT07005154Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer, Metastatic Hormone Sensitive Prostate Cancer
Astellas Pharma Global Development, Inc.
Phase 2
218
Bordeaux, Le Mans, Lille, Paris, Strasbourg
2025-08-19
Recruiting
University Hospital, Bordeaux
Not applicable
80
Bordeaux
2025-08-07
Active, closed
AstraZeneca
Phase 3
212
Amiens, Bois-Guillaume, Bordeaux, Lille, Paris
2025-08-07
Recruiting
AstraZeneca
Phase 3
700
Angers, Bordeaux, Caen, Clermont-Ferrand, Le Mans, Marseille, Montpellier, Nice
2025-08-06
Recruiting
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
227
Angers, Bordeaux, Caen, Créteil, Grenoble, Lille, Lyon, Montpellier
2025-08-05
Recruiting
AstraZeneca
Phase 3
800
Avignon, Besançon, Bordeaux, Chambray-lès-Tours, Cholet, Créteil, Grenoble, Lille
2025-08-01
Recruiting
Harmony TPV EMEA PMS
NCT06906926Severe Pulmonary Valve Regurgitation
Medtronic Cardiovascular
Not applicable
80
Bordeaux
2025-07-30
Recruiting
Visible Abdominal Distension
NCT06369753Irritable Bowel Syndrome, Dyspepsia, Functional Bloating
Hospital Universitari Vall d'Hebron Research Institute
Not applicable
100
Bordeaux
2025-07-30
Recruiting
Chiesi Farmaceutici S.p.A.
Phase 2/3
22
Bordeaux, Montpellier
2025-07-29
Recruiting
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
NCT07094204Solid Tumor, Non-Small-Cell Lung Cancer, Pancreatic Ductal Adenocarcinoma, Colorectal Cancer
Astellas Pharma Inc
Phase 1
404
Bordeaux, Lyon, Pierre-Bénite, Villejuif
2025-07-25
Recruiting
Hospices Civils de Lyon
Not applicable
482
Bordeaux, Dijon, Grenoble, Jossigny, Lille, Lyon, Marseille, Nantes
2025-07-25
Active, closed
French Prospective Multicentric Study in Real World
NCT07039942Diabetes, Diabetes Mellitus, Type 1 Diabetes
Insulet Corporation
Observational
304
Angers, Besançon, Bobigny, Bordeaux, Brest, Bron, Corbeil-Essonnes, Dijon
2025-07-23
Recruiting
CongenItal Naevus Cohort for Longitudinal Evaluation
NCT06828822Naevi, Neurodevelopmental Disorder, Congenital Nevus
Nantes University Hospital
Not applicable
819
Nice, Marseille, Dijon, La Réunion, Brest, Bordeaux, Toulouse, Rennes
2025-07-23
Active, closed
Lyv Healthcare
Not applicable
400
Aix-en-Provence, Caen, Rennes, Bordeaux, Le Chesnay, Le Mans, Lille, Paris
2025-07-21
Recruiting
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
NCT06765109Non-small Cell Lung Cancer, Anaplastic Lymphoma Kinase-positive
Nuvalent Inc.
Phase 3
450
Angers, Bordeaux, Caen, Lyon, Marseille, Montpellier, Nantes, Paris
2025-07-17
Recruiting
Takeda
Phase 3
347
Créteil, Bordeaux, Limoges, Montpellier, Nantes, Paris
2025-07-15
Not yet open
University Hospital, Bordeaux
Not applicable
200
Bordeaux
2025-07-07
Not yet open
University Hospital, Bordeaux
Phase 3
50
Bordeaux
2025-07-05
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
360
Bordeaux, Lille, Saint-Herblain, Bayonne, Pierre-Bénite
2025-07-03
Recruiting
Gustave Roussy, Cancer Campus, Grand Paris
Phase 2
40
Bordeaux, Nice, Villejuif
2025-07-02
Not yet open
Effects of a Digital Exercise Intervention on Sleep and Physical Activity in Patients With Spondyloarthritis
NCT07034404Spondylarthritis, Spondylarthropathies; Spondylitis, Ankylosing
University Hospital, Grenoble
Not applicable
100
Bordeaux, Clermont-Ferrand, Saint-Etienne
2025-07-01
Recruiting
Timing of Renal Replacement Therapy Initiation in Tumor Lysis Syndrome
NCT06889974Renal Replacement Therapy for Acute Kidney Injury in ICU
University Hospital, Bordeaux
Observational
800
Angers, Bordeaux, Brest, Limoges, Nantes, Orléans, Pau, Rennes
2025-07-01
Not yet open
University Hospital, Bordeaux
Not applicable
100
Bordeaux
2025-07
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
14
Bordeaux, Lille, Marseille, Paris, Toulouse
2025-06-26
Recruiting
Domain Therapeutics Australia Pty Ltd
Phase 1/2
125
Bordeaux, Strasbourg, Villejuif
2025-06-25
Recruiting
Assistance Publique - Hôpitaux de Paris
Phase 3
134
Bordeaux, Boulogne-Billancourt, Caen, Créteil, Grenoble, Le Kremlin-Bicêtre, Lyon, Melun
2025-06-24
Active, closed
Incyte Corporation
Phase 3
580
Bordeaux, Brest, Nantes, Nice, Paris
2025-06-23
Recruiting
Novartis Pharmaceuticals
Phase 3
400
Bordeaux, Clermont-Ferrand, Lille, Marseille, Nice, Nîmes, Paris, Poitiers
2025-06-23
Recruiting
Assistance Publique - Hôpitaux de Paris
Phase 3
86
Besançon, Bordeaux, Brest, Bron, Le Kremlin-Bicêtre, Lille, Montpellier, Strasbourg
2025-06-23
Active, closed
Novartis Pharmaceuticals
Phase 1/2
27
Bordeaux, Brest, Le Kremlin-Bicêtre, Lille
2025-06-20
Not yet open
University Hospital, Tours
Phase 3
290
Amiens, Angers, Assistance Publique Hôpitaux de Paris, Besançon, Bordeaux, Caen, CH Intercommunal de Créteil, Clermont-Ferrand
2025-06-17
Recruiting
First-in-human Trial of STC-1010, an Immunotherapy, in Patients With Unresectable Locally Advanced or Metastatic Colorectal Cancer
NCT06934538Unresectable Metastatic Colorectal Cancer, Unresectable Locally Advanced Colorectal Cancer
Brenus Pharma
Phase 1/2
90
Bordeaux, Dijon, Lyon, Montpellier, Poitiers, Villejuif
2025-06-17
Active, closed
Incyte Corporation
Phase 3
159
Bordeaux, Reims, Romans-sur-Isère
2025-06-17
Recruiting
Nantes University Hospital
Not applicable
362
Angers, Bordeaux, Grenoble, Lyon, Marseille, Nantes, Paris, Rennes
2025-06-17
Recruiting
Relay Therapeutics, Inc.
Phase 2
277
Amiens, Bordeaux, Marseille, Paris
2025-06-13
Active, closed
Merck Sharp & Dohme LLC
Phase 2
149
Lyon, Bordeaux, Toulon, Paris
2025-06-09
Recruiting
University Hospital, Toulouse
Phase 4
308
Toulouse, Amiens, Bordeaux, Brest, Clermont-Ferrand, Le Mans, Lille, Limoges
2025-06-06
Recruiting
AstraZeneca
Phase 3
15,100
Bordeaux, Brest, Bron, Corbeil-Essonnes, Dijon, La Tronche, Lille, Limoges
2025-06-04
Not yet open
Pilot Study of PEnile TRAnsplantation - Vascularized Composite Allografts
NCT06781606Adults with Traumatic Penile Severe Defects, Congenital Penile Defects, Micropenis
Hospices Civils de Lyon
Not applicable
3
Bordeaux, Lille, Lyon, Marseille, Montpellier, Pierre-Bénite, Suresnes, Toulouse
2025-06-01
Recruiting
Ruxolitinib Treatment in Inclusion Body Myositis
NCT06536166Inclusion Body Myositis, Sporadic
Assistance Publique - Hôpitaux de Paris
Phase 2
80
Angers, Bayonne, Besançon, Bordeaux, Brest, Bron, Caen, Créteil
2025-05-27
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
50
Bordeaux, Marseille, Nantes, Lyon, Paris
2025-05-26
Active, closed
Alkermes, Inc.
Phase 2
126
Bordeaux, Montpellier, Grenoble
2025-05-22
Recruiting
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
NCT06901531Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer, Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
Astellas Pharma Global Development, Inc.
Phase 3
500
Bordeaux, Brest, Caen, Carassonne, Dijon, Lille, Lyon, Montpellier
2025-05-22
Active, closed
Swedish Orphan Biovitrum
Phase 4
252
Bordeaux, Marseille, Montpellier, Nantes, Paris, Rennes, Rouen
2025-05-21
Recruiting
Effectiveness of PKP vs DSAEK in Terms of 2-year Postoperative Visual Acuity in Advanced BPK
NCT06818747Bullous Pseudophakic Keratopathy, Penetrating Keratoplasty
Centre Hospitalier Régional Metz-Thionville
Not applicable
334
Besançon, Bordeaux, Brest, Metz, Nantes, Paris, Saint-Etienne, Strasbourg
2025-05-21
Recruiting
University Hospital, Brest
Phase 4
2,400
Amiens, Bordeaux, Brest, Clamart, Clermont-Ferrand, La Roche-sur-Yon, Le Kremlin-Bicêtre, Marseille
2025-05-16
Recruiting
Perioperative Durvalumab With Neoadjuvant ddMVAC in Patients With Muscle-Invasive Bladder Cancer (NIAGARA-2)
NCT06960577Urinary Bladder Neoplasms, Immune Checkpoint Inhibitors, Methotrexate, Vinblastine
AstraZeneca
Phase 2
150
Angers, Bordeaux, Chambray-lès-Tours, Dijon, Lille, Lyon, Marseille, Montpellier
2025-05-15
Recruiting
University Hospital, Brest
Not applicable
250
Brest, Amiens, Angers, Bordeaux, Marseille, Nantes, Nice, Rouen
2025-05-15
Recruiting
Initial Standardized Global Review in Axial Spondyloarthritis
NCT07141017Axial Spondylarthritis (axSpA)
Association de Recherche Clinique en Rhumatologie
Not applicable
154
Besançon, Bordeaux, Brest, Caen, Clermont-Ferrand, Créteil, La Roche-sur-Yon, Le Kremlin-Bicêtre
2025-05-12
Recruiting
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
NCT06563895Amyloidosis, Amyloid Cardiomyopathy, Transthyretin Amyloidosis, Cardiomyopathies
Eidos Therapeutics, a BridgeBio company
Phase 3
587
Bordeaux, Créteil, Le Kremlin-Bicêtre, Rennes, Toulouse
2025-05-12
Recruiting
Biogen
Phase 3
454
Strasbourg, Besançon, Bordeaux, Reims, Mulhouse, Suresnes, Orléans, Nîmes Cédex 9
2025-05-08
Recruiting
"Continuous Positive Airway Pressure on Venovenous extracorporeaL Membrane Oxygenation for Acute respIratory Distress syndrOme"
NCT06814340Acute Respiratory Distress Syndrome, Extracorporeal Membrane Oxygenation Complication
Assistance Publique - Hôpitaux de Paris
Phase 3
280
Bobigny, Bordeaux, Créteil, Lyon, Marseille, Metz, Nancy, Orléans
2025-05-06
Active, closed
FARAPULSE Workflow Assessment Registry
NCT06656884Atrial Fibrillation (AF)
Boston Scientific Corporation
Observational
524
Bordeaux, Lomme, Tours
2025-05-06
Recruiting
AstraZeneca
Phase 1
72
Bordeaux, Montpellier, Nancy, Paris, Strasbourg, Toulouse
2025-05-01
Not yet open
Hospices Civils de Lyon
Not applicable
80
Bordeaux, Lille, Saint-Genis-Laval
2025-05-01
Recruiting
Fondation Ophtalmologique Adolphe de Rothschild
Phase 3
128
Bordeaux, Garches, Lille, Lyon, Nice, Paris, Strasbourg, Toulouse
2025-04-29
Recruiting
Centre Hospitalier Universitaire de Nice
Phase 3
420
Nice, Bordeaux, Nantes, Rouen, Sainte-Maxime, Argenteuil, Brest, Cenon
2025-04-29
Active, closed
Novartis Pharmaceuticals
Phase 1/2
15
Bordeaux, Brest, Lille
2025-04-22
Recruiting
University Hospital, Bordeaux
Not applicable
20
Bordeaux
2025-04-16
Recruiting
Institut du Cancer de Montpellier - Val d'Aurelle
Not applicable
254
Dijon, Nîmes, Bordeaux, Montpellier, Angers, Lyon
2025-04-15
Recruiting
University Hospital, Bordeaux
Not applicable
90
Bordeaux
2025-04-15
Recruiting
Pyxis Oncology, Inc
Phase 1/2
220
Bordeaux, Lyon, Marseille, Villejuif
2025-04-15
Not yet open
University Hospital, Bordeaux
Not applicable
60
Bordeaux, Pessac, Toulouse
2025-04-15
Recruiting
Hospices Civils de Lyon
Phase 2
58
Bordeaux, Brest, Bron, Caen, Clermont-Ferrand, Grenoble, Lyon, Nantes
2025-04-11
Recruiting
AbbVie
Phase 2
300
Nice, Caluire-et-Cuire, Chambray-lès-Tours, Orléans, Bordeaux
2025-04-11
Recruiting
Merck Sharp & Dohme LLC
Phase 3
770
Lille, Bordeaux, Pierre-Bénite, Caen, Plérin, Toulouse, Chambray-lès-Tours, Paris
2025-04-09
Recruiting
Institut Claudius Regaud
Not applicable
150
Angers, Bordeaux, Caen, Lille, Lyon, Marseille, Montpellier, Nantes
2025-04-07
Recruiting
Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors
NCT06726148Advanced HR+/HER2- Breast Cancer, Advanced CCNE1-amplified Solid Tumors, Extensive-stage Small Cell Lung Cancer
Novartis Pharmaceuticals
Phase 1/2
280
Bordeaux, Saint-Herblain
2025-04-03
Recruiting
Cardiovascular and Interventional Radiological Society of Europe
Observational
50
Bordeaux, Strasbourg, Villejuif
2025-04-01
By invitation
Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP
NCT06859099Polyneuropathy, Inflammatory Demyelinating, Chronic
Sanofi
Phase 3
300
Bordeaux, Le Kremlin-Bicêtre, Marseille, Montpellier, Paris
2025-04-01
Recruiting
University Hospital, Bordeaux
Not applicable
40
Bordeaux, Nantes
2025-04-01
Recruiting
Prescient Therapeutics, Ltd.
Phase 2
115
Bordeaux, Lyon, Paris
2025-03-28
Recruiting
RapidPulse, Inc
Not applicable
170
Bordeaux, Montpellier, Toulouse
2025-03-27
Recruiting
University Hospital, Bordeaux
Not applicable
388
Bordeaux
2025-03-25
Recruiting
Multimodal Biocollection Linked to the French Register of Intracranial Aneurysms
NCT06689410Aneurysm, Brain Aneurysm, Congenital Disease
Nantes University Hospital
Not applicable
1,100
Nantes, Amiens, Angers, Besançon, Bordeaux, Brest, Caen, Clermont-Ferrand
2025-03-25
Recruiting
Medtronic MiniMed, Inc.
Not applicable
40
Bordeaux, Corbeil-Essonnes, Lille, Montpellier, Nancy, Toulouse, Dijon, Marseille
2025-03-21
Recruiting
Daiichi Sankyo
Phase 3
582
Bordeaux, Dijon, Lille, Lyon, Montpellier, Nantes, Paris, Rennes
2025-03-19
Active, closed
Hoffmann-La Roche
Phase 4
274
Bordeaux, Lyon, Paris, Saint-Cyr-sur-Loire, Saint-Jean
2025-03-14
Recruiting
Insel Gruppe AG, University Hospital Bern
Phase 4
906
Bordeaux, Grenoble, Lille, Lyon, Montpellier, Nancy, Paris, Perpignan
2025-03-14
Recruiting
Center Eugene Marquis
Phase 2
34
Bobigny, Bordeaux, Clichy, Nantes, Rennes, Villejuif
2025-03-12
Recruiting
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
NCT06833073Urinary Bladder Neoplasms, Non-Muscle Invasive Bladder Neoplasms, Carcinoma in Situ
Merck Sharp & Dohme LLC
Phase 2
308
Dijon, Bordeaux, Rouen, Suresnes, Paris
2025-03-11
Recruiting
UNICANCER
Phase 2
220
Amiens, Avignon, Bayonne, Besançon, Bordeaux, Caen, Dijon, La Roche-sur-Yon
2025-03-11
Recruiting
Rein 3D PRINT MECHANICS
NCT06525831Kidney Cancer
University Hospital, Bordeaux
Not applicable
50
Bordeaux
2025-03-07
Recruiting
Phenox GmbH
Observational
200
Amiens, Bordeaux, Bron, Clermont-Ferrand, Le Kremlin-Bicêtre, Limoges, Paris, Reims
2025-03-07
Active, closed
A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer
NCT06521567Melanoma, Hodgkin Lymphoma, High and Low Grade Glioma, Glioblastoma Multiforme (GBM)
GlaxoSmithKline
Phase 1/2
83
Bordeaux, Lyon, Paris, Strasbourg, Villejuif
2025-03-06
Recruiting
AstraZeneca
Phase 3
5,000
Amiens, Bordeaux, Boulogne-Billancourt, Brest, Clermont-Ferrand, Créteil, La Roche-sur-Yon, Le Mans
2025-03-03
Recruiting
AstraZeneca
Phase 3
840
Bordeaux, Caen, Clermont-Ferrand, Dijon, Lyon, Marseille, Poitiers, Rennes
2025-03-01
Not yet open
University Hospital, Bordeaux
Observational
1,400
Bordeaux
2025-03-01
Not yet open
Arginin-stimulated Copeptin in Polyuria-polydipsia Syndrome in Children
NCT06604975Primary Polydipsia, Central Diabetes Insipidus, Nephrogenic Diabetes Insipidus
Assistance Publique Hopitaux De Marseille
Not applicable
155
Angers, Bordeaux, Lille, Lyon, Marseille, Montpellier, Nantes, Nice
2025-03
Recruiting
Centre Hospitalier Universitaire de Besancon
Not applicable
226
Besançon, Bordeaux, Grenoble, Lille, Lyon, Marseille, Nancy, Nantes
2025-03
Recruiting
Incyte Corporation
Phase 3
600
Antony, Bordeaux, Brest, Créteil, Lyon, Marseille, Nantes, Nice
2025-02-28
Recruiting
Nantes University Hospital
Observational
450
Nantes, Bordeaux, Clamart, Le Plessis-Robinson, Marseille, Paris, Toulouse, Tours
2025-02-28
Recruiting
Training Cognition With Neurofeedback After Stroke
NCT06852209Stroke, Cognitive Impairment
University Hospital, Bordeaux
Not applicable
20
Bordeaux
2025-02-28
Recruiting
Amgen
Phase 3
844
Bordeaux, Brest, Mulhouse, Paris, Strasbourg
2025-02-25
Recruiting
Novartis Pharmaceuticals
Phase 2
20
Bordeaux, Lille, Lyon, Nantes, Paris, Vandœuvre-lès-Nancy
2025-02-18
Recruiting
Novo Nordisk A/S
Phase 3
510
Bobigny, Bordeaux, Créteil, Grenoble, Lyon, Paris, Rouen
2025-02-17
Recruiting
University Hospital, Bordeaux
Not applicable
10
Bordeaux
2025-02-17
Recruiting
Bayer
Phase 2
111
Pierre-Bénite, Brest, Lille, Bordeaux, Montpellier, Villejuif
2025-02-13
Recruiting
Dianthus Therapeutics
Phase 3
256
Bordeaux, Brest, Bron, Clermont-Ferrand, Libourne, Marseille, Nice, Paris
2025-02-10
Active, closed
Novartis Pharmaceuticals
Phase 3
180
Bordeaux, Nice, Paris, Strasbourg, Toulouse
2025-02-07
Active, closed
Sanofi
Phase 3
216
Bordeaux, Marseille, Nantes, Poitiers, Pontoise, Toulouse
2025-02-06
Active, closed
The Leeds Teaching Hospitals NHS Trust
Observational
550
Bordeaux, Brest, Créteil, Massy, Montpellier, Paris, Saint-Cyr-sur-Loire, Strasbourg
2025-02-04
Active, closed
Sanofi
Observational
600
Aix-en-Provence, Amiens, Angers, Arès, Bayonne, Bezannes, Biarritz, Bordeaux
2025-02-04
Recruiting
Topadur Pharma AG
Phase 2
15
Bordeaux, La Tronche, Lille, Paris
2025-02-04
Recruiting
Bristol-Myers Squibb
Phase 1/2
416
Nice, Bordeaux, Lyon, Marseille, Caen, Montpellier, Villejuif, Paris
2025-02-04
Recruiting
Centre Hospitalier Universitaire de Nice
Phase 3
120
Besançon, Bordeaux, Caen, Créteil, Lyon, Marseille, Nice, Nîmes
2025-02-04
Recruiting
BioNTech SE
Phase 3
621
Angers, Bordeaux, Caen, Paris, Rennes, Saint-Herblain, Toulon
2025-02-03
Recruiting
Bristol-Myers Squibb
Observational
350
Amiens, Angers, Argenteuil, Arras, Bordeaux, Chalon-sur-Saône, Clermont-Ferrand, Dijon
2025-01-29
Active, closed
Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)
NCT06710132Solid Tumors, Gastric Cancer, Non-Small Cell Lung Cancer (NSCLC), Pancreatic Cancer
DrugM9140
EMD Serono Research & Development Institute, Inc.
Phase 1/2
184
Bordeaux, Dijon, Lille, Paris, Saint-Herblain, Suresnes, Toulouse, Villejuif
2025-01-29
Recruiting
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
NCT06788990Metastatic Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma
Bicara Therapeutics
Phase 2/3
650
Amiens, Bordeaux, Lille, Lyon, Paris, Rennes, Saint-Grégoire, Strasbourg
2025-01-28
Recruiting
ANRS, Emerging Infectious Diseases
Phase 3
610
Bordeaux, Montpellier, Nantes, Paris
2025-01-27
Recruiting
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
NCT06767683Narcolepsy Type 1, Narcolepsy Type 2, Idiopathic Hypersomnia
Alkermes, Inc.
Phase 2/3
786
Montpellier, Bordeaux
2025-01-27
Recruiting
UNICANCER
Phase 2
198
Angers, Besançon, Bordeaux, Caen, Clermont-Ferrand, Dijon, Limoges, Lyon
2025-01-27
Recruiting
Assistance Publique - Hôpitaux de Paris
Phase 2
52
Paris, Amiens, Angers, Besançon, Bordeaux, Caen, Clamart, Clermont-Ferrand
2025-01-24
Recruiting
Pfizer
Not applicable
90
Toulouse, Paris, Aix-en-Provence, Albi, Amiens, Avignon, Bordeaux, Brest
2025-01-20
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
290
Bordeaux, Boulogne-Billancourt, Brest, Cergy-Pontoise, Créteil, Dijon, Lyon, Marseille
2025-01-20
Recruiting
ETOP IBCSG Partners Foundation
Phase 3
290
Angers, Bordeaux, Le Mans, Lyon
2025-01-15
Not yet open
University Hospital, Bordeaux
Not applicable
252
Bordeaux, Boulogne-Billancourt, Castelnau-le-Lez, Dijon, Grenoble, Lyon, Nice, Paris
2025-01-15
Recruiting
Centre Leon Berard
Not applicable
236
Angers, Besançon, Bordeaux, Caen, Lille, Lyon, Nancy, Nice
2025-01-14
Recruiting
BeOne Medicines
Phase 1
695
Bordeaux, Marseille, Paris, Saint-Herblain, Villejuif
2025-01-10
Recruiting
Galimedix Therapeutics Inc
Phase 2
110
Bordeaux, Lyon, Marseille, Paris, Tours
2025-01-10
Recruiting
Institut Claudius Regaud
Not applicable
130
Angers, Bordeaux, Limoges, Nîmes, Saint-Herblain, Toulouse
2025-01-08
Recruiting
BioNTech SE
Phase 2/3
1,580
Angers, Bayonne, Bordeaux, Bron, Caen, Clermont-Ferrand, Créteil, La Tronche
2025-01-07
Active, closed
Pfizer
Phase 3
1,035
Bayonne, Bordeaux, Lille, Saint-Cloud, Rennes, Montpellier, Saint-Herblain, Angers
2025-01-06
Active, closed
Brain Oligometastasis in NSCLC
NCT07389642Brain Oligometastatic, Non-small Cell Lung Cancer
University Hospital, Bordeaux
Observational
46
Bordeaux
2025-01-01
Recruiting
Fondation Hôpital Saint-Joseph
Observational
2,000
Bordeaux, Le Plessis-Robinson, Lille, Toulouse
2025-01-01
Not yet open
University Hospital, Strasbourg, France
Phase 3
200
Bordeaux, Caen, Clermont-Ferrand, Créteil, Dijon, Gonesse, La Tronche, Lille
2025-01
Recruiting
Elsan
Not applicable
510
Avignon, Besançon, Bordeaux, Cabestany, Caen, Le Mans, Nancy, Ollioules
2024-12-30
Recruiting
Santen SAS
Phase 3
234
Bordeaux, Guillon, Paris, Saint-Etienne
2024-12-30
Recruiting
UNICANCER
Phase 2
354
Amiens, Avignon, Bayonne, Bordeaux, Caen, Clermont-Ferrand, Dijon, Levallois-Perret
2024-12-27
Recruiting
Nantes University Hospital
Not applicable
170
Bordeaux, Clermont-Ferrand, Grenoble, Lyon, Marseille, Nancy, Nantes, Paris
2024-12-18
Recruiting
Assistance Publique Hopitaux De Marseille
Not applicable
60
Bordeaux, Bron, Lille, Marseille, Paris, Rennes, Toulouse
2024-12-18
Active, closed
argenx
Phase 3
154
Bordeaux, Brest, Bron, Le Kremlin-Bicêtre, Lille, Limoges, Marseille, Nice
2024-12-18
Active, closed
Institut de Recherches Internationales Servier
Phase 1/2
55
Bordeaux, Clichy, Montpellier
2024-12-16
Recruiting
A Study to Investigate ALE.P02 as a Monotherapy or in Combination With Pembrolizumab in Adult Patients With Selected CLDN1+ Solid Tumors
NCT06747585Squamous Non-small-cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Esophageal Squamous Cell Carcinoma
Alentis Therapeutics AG
Phase 1/2
235
Bordeaux, Dijon, Lille, Marseille, Toulouse, Villejuif
2024-12-16
Recruiting
Hoffmann-La Roche
Phase 3
500
Amiens Cedex1, Bayonne, Besançon, Bordeaux, Brest, Bron, Caen, Clermont-Ferrand
2024-12-13
Recruiting
Synergistic Effect of Non-invasive Brain and Spinal Cord Stimulation
NCT07334977Stroke, Spinal Cord Injury, Able Bodied
Centre National de la Recherche Scientifique, France
Phase 2
45
Bordeaux, Bruges
2024-12-11
Active, closed
ARCAGY/ GINECO GROUP
Phase 2
77
Angers, Avignon, Besançon, Bordeaux, Brest, Caen, Clermont-Ferrand, Créteil
2024-12-11
Active, closed
Amgen
Phase 3
707
Bordeaux, Clermont-Ferrand, La Tronche, Le Mans, Lille, Lyon, Marseille, Nice
2024-12-09
Recruiting
Evaluation of Salivary RNA in Subjects Scheduled for Surgery for a Gynecologic Pathology
NCT06392997Gynecologic Disease, Gynecologic Cancer, Endometriosis, Ovarian Cancer
ZIWIG
Observational
2,500
Angers, Bordeaux, Caen, Dijon, Lyon, Neuilly-sur-Seine, Rennes, Rouen
2024-12-05
Recruiting
Nosocomial Respiratory Virus Infection
NCT06643039Nosocomial Infections
Hospices Civils de Lyon
Not applicable
1,000
Bordeaux, Dijon, Lyon, Paris
2024-12-05
Recruiting
Elacestrant + Everolimus in Patients ER+/HER2-, ESR1mut, Advanced Breast Cancer Progressing to ET and CDK4/6i.
NCT06382948Advanced Breast Cancer, ER-positive Breast Cancer, HER2-negative Breast Cancer, ESR1 Gene Mutation
MedSIR
Phase 3
300
Bordeau, Bordeaux, Dijon, Limoges, Lyon, Marseille, Paris, Plérin
2024-12-05
Recruiting
University Hospital, Rouen
Phase 4
133
Amiens, Angers, Argenteuil, Bobigny, Bordeaux, Brest, Caen, Clermont-Ferrand
2024-12-04
Active, closed
Biogen
Phase 3
132
Bordeaux, La Tronche, Lyon, Toulouse
2024-12-03
Active, closed
H. Lundbeck A/S
Phase 3
401
Rennes, Lille, Bordeaux, Montpellier, Toulouse, Marseille, Paris
2024-12-03
Recruiting
The Role of Cxcr4Hi neutrOPhils in InflueNza
NCT06254313Influenza, Acute Respiratory Distress Syndrome
University Hospital, Bordeaux
Observational
90
Bordeaux, Pessac
2024-12
Recruiting
University Hospital, Bordeaux
Phase 3
358
Bordeaux
2024-11-28
Active, closed
Genmab
Phase 3
191
Marseille, Bordeaux, Paris, Bayonne, Avignon, Villejuif, Angers, Boulogne-Billancourt
2024-11-25
Recruiting
Study to Assess Safety, Tolerability and Activity of DSB2455 in Participants With Advanced Malignancies
NCT06458712Advanced Cancers (Breast, Ovarian, mCRPC, Pancreatic Ductal Adenocarcinoma (PDAC), Brain Mets) With Specific Mutations (Homologous Recombination Deficiency)
Duke Street Bio Ltd
Phase 1
180
Bordeaux, Reims
2024-11-21
Recruiting
UCB Biopharma SRL
Phase 3
450
Bordeaux, Le Mans, Montpellier
2024-11-21
Recruiting
ADDICTOlogical Intervention in LIVEr Transplantation Recipients
NCT06472973Alcohol Associated Liver Disease, Liver Transplantation
University Hospital, Montpellier
Not applicable
720
Besançon, Bordeaux, Clermont-Ferrand, Dijon, Lille, Lyon, Marseille, Montpellier
2024-11-21
Recruiting
International CRDS Registry
NCT06508164Calcium Release Deficiency Syndrome
Population Health Research Institute
Observational
500
Bordeaux
2024-11-21
Active, closed
A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)
NCT06422884Idiopathic Pulmonary Fibrosis, Progressive Fibrosing Interstitial Lung Disease
Endeavor Biomedicines, Inc.
Phase 2
213
Angers, Bordeaux, Caen, Dijon, Montpellier, Nantes, Paris, Rennes
2024-11-15
Recruiting
University Hospital, Clermont-Ferrand
Not applicable
120
Bordeaux, Clermont-Ferrand, Marseille, Toulouse
2024-11-15
Recruiting
Genentech, Inc.
Phase 1
410
Villejuif, Bordeaux, Dijon
2024-11-14
Active, closed
argenx
Phase 2
87
Lille, Bordeaux, Marseille, Montpellier, Paris
2024-11-11
Active, closed
University Hospital, Angers
Not applicable
607
Amiens, Angers, Bordeaux, Brest, Bron, Caen, Chalon-sur-Saône, Cholet
2024-11-11
Recruiting
Anti-GD2 ADC M3554 in Advanced Solid Tumors
NCT06641908Advanced Solid Tumor
EMD Serono Research & Development Institute, Inc.
Phase 1
65
Bordeaux, Lille, Lyon, Nice
2024-11-08
Active, closed
Alnylam Pharmaceuticals
Phase 1/2
89
Bordeaux, Bron
2024-11-07
Recruiting
Imagine Institute
Observational
400
Amiens, Angers, Besançon, Bordeaux, Brest, Clermont-Ferrand, Grenoble, Lille
2024-10-31
Recruiting
Institut National de la Santé Et de la Recherche Médicale, France
Not applicable
1,020
Amiens, Angers, Besançon, Bordeaux, Brest, Corbeil-Essonnes, Dijon, Grenoble
2024-10-30
Recruiting
EXtensive mulTilayer stEnt treatmeNt in Aortic disSectiOn
NCT06675617Type B Aortic Dissection
Intressa Vascular SA
Not applicable
72
Bordeaux, Paris
2024-10-30
Recruiting
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
NCT06625775Solid Tumor, Adult, Metastatic Breast Cancer, Advanced Breast Cancer, HER2 Mutation-Related Tumors
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Phase 1
392
Montpellier, Saint-Cloud, Saint-Herblain, Bordeaux, Lyon, Villejuif
2024-10-29
Active, closed
Novartis Pharmaceuticals
Phase 2
96
Bordeaux, Dijon, Lille, Lyon, Montpellier, Paris, Rennes, Strasbourg
2024-10-29
Recruiting
Vulnerability and Risk of Neuropathic Pain in Cancer
NCT06511674Neuropathic Pain, Cancer, Predictive
University Hospital, Clermont-Ferrand
Not applicable
625
Ajaccio, Angers, Aurillac, Bordeaux, Caen, Clermont-Ferrand, Colmar, Dijon
2024-10-28
Active, closed
Eli Lilly and Company
Phase 2
45
Bordeaux, Lille, Lyon, Marseille, Paris, Villejuif
2024-10-25
Active, closed
Nantes University Hospital
Phase 1/2
21
Bordeaux, Nantes, Angers, Clermont-Ferrand
2024-10-22
Recruiting
Pfizer
Phase 3
900
Bordeaux, Lyon Cedex08, Strasbourg, Brest, Saint-Grégoire, Saint-Herblain, Reims, Le Mans
2024-10-22
Active, closed
Institut Claudius Regaud
Phase 2
86
Amiens, Avignon, Bordeaux, Clermont-Ferrand, Limoges, Marseille, Nantes, Nice
2024-10-21
Active, closed
Streamlined Geriatric and Oncological Evaluation Based On IC Technology
NCT05720910Breast Cancer, Comorbidities and Coexisting Conditions, Lung Cancer, Colorectal Cancer
Institut Bergonié
Not applicable
720
Bayonne, Bordeaux, Dinan, La Roche-sur-Yon, Lyon, Mougins, Nice, Paris
2024-10-15
Recruiting
Rennes University Hospital
Observational
80
Nîmes, Paris, Rennes, Bordeaux, Brest, Caen, Clermont-Ferrand, Créteil
2024-10-11
Recruiting
Diagnostic HER2DX-guided Treatment for Patients wIth Early-stage HER2-positive Breast Cancer
NCT06446882HER2-positive Breast Cancer, Early-stage Breast Cancer
Fundacio Clinic Barcelona
Not applicable
304
Avignon, Bordeaux, Léon, Marseille, Nancy, Paris, Toulouse
2024-10-11
Recruiting
Boehringer Ingelheim
Phase 2
588
Bordeaux, Dijon, Lyon, Marseille, Poitiers, Villejuif
2024-10-11
Active, closed
SynOx Therapeutics Limited
Phase 3
128
Bordeaux, Saint-Herblain, Paris, Lyon, Lille, Toulouse
2024-10-09
Recruiting
Efficacy of INM004 in Children With STEC-HUS
NCT06389474Hemolytic-Uremic Syndrome
Inmunova S.A.
Phase 3
220
Bordeaux, Lyon, Montpellier, Nantes, Paris, Rouen
2024-10-05
Active, closed
AstraZeneca
Phase 3
768
Bordeaux, Caen, Lille, Montpellier, Nantes, Paris, Pessac, Toulon Armees
2024-10-04
Recruiting
SoniVie Inc.
Not applicable
261
Bordeaux, Paris
2024-10-03
Active, closed
Teva Branded Pharmaceutical Products R&D LLC
Phase 2
349
Bordeaux, Caen, Marseille, Paris, Toulouse
2024-10-02
Recruiting
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
Phase 2
30
Aix-en-Provence, Marseille, Toulon, Angers, Bordeaux, Brest, Caen, Chambéry
2024-10-01
Recruiting
Ferring Pharmaceuticals
Phase 3
454
Clermont-Ferrand, Toulouse, Nantes, Bordeaux, Rouen, Nîmes, Lyon, Paris
2024-10-01
Recruiting
Ferring Pharmaceuticals
Phase 3
250
Clermont-Ferrand, Lyon, Toulouse, Nantes, Bordeaux, Nîmes, Paris
2024-10-01
Recruiting
Dexamethasone and Pregnancy: Maternal Effects
NCT06259994Dexamethasone During Pregnancy
Assistance Publique - Hôpitaux de Paris
Observational
35
Bordeaux, Bron, Grenoble, Le Kremlin-Bicêtre, Lille, Nantes, Paris, Toulouse
2024-09-30
Recruiting
GlaxoSmithKline
Phase 1
845
Bordeaux, Lyon, Villejuif
2024-09-30
Active, closed
Genmab
Phase 3
699
Bordeaux, Le Mans, Lille, Lyon, Marseille, Montpellier, Nice, Paris
2024-09-25
Active, closed
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
NCT06561685Metastatic Solid Tumor, Advanced Solid Tumor, Non-small Cell Lung Cancer, SMARCA4-Deficient Tumor
Eli Lilly and Company
Phase 1
340
Bordeaux, Paris, Villejuif
2024-09-19
Recruiting
Ambulatory Geriatric Endoscopic Spine
NCT06523426Lumbar Decompression
University Hospital, Bordeaux
Observational
50
Bordeaux, Bruges, Saint-Jean-de-Védas
2024-09-18
Rows per page Showing 1–500 of 1393
1 2 3 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a French investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 16 November 2026. https://priyalifescience.com/clinical-trials-france/city/bordeaux

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in France and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,729 studies in total at the last sync on 14 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 1,393 of those studies with a site in Bordeaux.

How many clinical trials are recruiting in Bordeaux?

754 of the 1,393 studies on this page are recruiting new participants as of the 14 Nov 2026, 03:18 UTC sync. A further 114 have not yet opened recruitment, 517 are active but closed to new participants, and 8 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Bordeaux), 1,393 studies
PhaseStudiesRecruitingShare
Phase 340717829.2%
Not applicable28719620.6%
Observational24114717.3%
Phase 222510516.2%
Phase 1/2104587.5%
Phase 172325.2%
Phase 2/334262.4%
Phase 423121.7%

Most active sponsors

Lead sponsors with the most studies (Bordeaux)
Lead sponsorStudiesRecruiting
University Hospital, Bordeaux12779
AstraZeneca6219
Assistance Publique - Hôpitaux de Paris4431
UNICANCER4018
Novartis Pharmaceuticals3316
Merck Sharp & Dohme LLC2912
Hoffmann-La Roche289
Nantes University Hospital2719
Hospices Civils de Lyon2615
Institut Bergonié2313
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.